Podcasts about fda

On this episode of Longevity by Design, Dr. Gil Blander sits down with Dr. Karl Pfleger, aging biotechnology investor and creator of AgingBiotech.info, to dissect the rapidly evolving field of aging therapeutics. Karl breaks down the sector into two main categories: interventions that slow aging rates versus rejuvenation strategies that repair accumulated damage.Karl highlights the most promising areas in his investment portfolio, including senolytics for clearing senescent cells and epigenetic reprogramming technologies. He explains why current aging clocks aren't ready for clinical use and discusses the limitations of popular interventions like GLP-1 drugs and fasting protocols. The conversation reveals that 14 Phase 3 clinical trials are currently testing core aging therapeutics.The discussion covers recent FDA approvals for ATTR treatments and stem cell therapies, signaling the field's maturation. Karl emphasizes that meaningful life extension requires a "divide and conquer" strategy, targeting multiple aging mechanisms simultaneously rather than relying on single interventions. Despite exciting therapeutic developments, he maintains that optimizing diet, exercise, and sleep remains the most impactful strategy for extending healthspan today.Guest-at-a-Glance

In this deeply soothing guided sleep meditation, Clara gently leads you on a symbolic journey over seven bridges, each one representing an emotional burden you're ready to release: fear, self-doubt, stress, blame, negativity, people-pleasing, and procrastination.   As you walk through tranquil pine forests, wildflower meadows, and blooming orchards, you'll let go of what no longer serves you and reconnect with the feeling of home, a place of rest, belonging and peacefulness. This immersive sleep story is perfect for unwinding, emotional healing, and falling into a deep, restorative sleep.   Support deeper rest naturally To enhance your sleep journey, try Sleep Well Gummies by Your Sleep Guru®. Formulated with melatonin, passionflower, and vitamin B6, these gentle, non-GMO supplements support healthy sleep cycles and promote natural relaxation. Crafted in FDA-registered, GMP-certified facilities and third-party tested for purity. CLICK HERE   Your Sleep Guru™ is independently created to support your well-being through original, ad-free storytelling. If you enjoy the experience, consider subscribing or sharing the episode because it helps support independent artists and keeps this podcast going.  

BOSSes, Anne Ganguzza and Tom Dheere dive into a lively and often debated topic for voiceover professionals: industry awards. Prompted by Anne's multiple Award nominations, they explore whether these accolades are simply vanity projects or powerful marketing tools. This episode delves into evolving perspectives on awards, the true meaning of a nomination, and practical strategies for leveraging any recognition to propel your voiceover business forward. They emphasize understanding the subjective nature of awards and how to use them for credibility, even beyond winning.   00:40 - Anne (Host) Hey everyone, welcome to the VO Boss Podcast. I'm your host, Anne Ganguzza, and I'm here with real boss, Tom Dheere. Woo-hoo, hi, Tom Dheere. I feel like there's pomp and circumstance for you, Tom Dheere, because it's that season again. Do you know what season it is? Deer season.  01:00 - Tom (Guest) Get it Tom Dheere, Deer season oh my God, that is really funny actually. That was terrible. It was not funny.  01:04 - Anne (Host) Well, okay, in addition to being deer season, right, it's award season. Woo-hoo, that's right it is award season. And I know there's always there's always always discussions about awards, and I've had discussions about awards before. I think we've probably talked about them before, but let's talk about them again, shall we? Because I think it's an ever-evolving thing and there are some people who are really for awards and some people who really detest awards.  01:32 - Tom (Guest) Yes, the reason why we're having this conversation, Anne, is because you got nominated for how many One Voice Awards.  01:41 - Anne (Host) Five why,thank you.  01:43 - Tom (Guest) Yes.  01:43 - Anne (Host) Why, thank you.  01:46 - Tom (Guest) I'm very excited about that. Wow, this is exciting and it's for all of the amazing work that you have gotten out of your students.  01:54 - Anne (Host) Yeah, for demos. 01:55 - Tom (Guest) That's amazing. Congratulations to you and all of your students. I'm very excited.  01:59 - Anne (Host) Yes, thank you, thank you. I like awards. I am one of those people that I actually endorse awards and I know some people think they're a vanity thing and in reality, for me it's always been about the marketing aspect. Tom, what are your thoughts?  02:15 - Tom (Guest) I used to be part of the anti-awards crew. I thought it was an exercise in vanity. I thought it was a money grab by the voiceover organizations that were hosting the awards, and my thoughts have evolved on the subject. Okay, I'd love to hear that. Well, I really do see now that it is truly a marketing tool and that is okay. All awards in all industries, from the Oscars all the way down to, you know, dog Catcher of the Year, these are all marketing. It's all about marketing. Is it about recognition? Yes. Is it a celebration of the industry in question? Yes. Is it to shine a spotlight on excellence, either from an individual or a group of individuals or a company, or whatever? Yes, is it to shine a spotlight on excellence either from an individual or a group of individuals or a company, or whatever? Yes, all of that is good and it should be supported. Is it an exercise of vanity? Yeah, sure, it's okay. There's nothing wrong with wanting to get dressed up and have people applaud you. There's nothing wrong with that, it's totally cool, it's totally cool.  03:22 - Anne (Host) Any excuse to get dressed up.  03:24 - Tom (Guest) Well, especially as voice actors who are stuck in closets in our pajamas all day,  03:27 - Anne (Host) Exactly exactly.  03:28 For me, it's always been marketing. First, because we have this whole conversation that awards are subjective. Right, I watch the awards, I watch the music awards, I watch the Emmys, the Oscars, I watch them all. Some people just they have so much to say about the awards, but honestly, I enjoy them if there's entertainment involved and I actually feel like it's wonderful when people get recognition that I feel deserve recognition. But of course, there's always the times where you're like I don't know how that person won or I don't know how that person didn't win, and so it is so very subjective and I think, first and foremost, we all need to remember that that is a fact. Right, it is very subjective and if you do not win an award, it has no bearing whatsoever on your worth or your quality at all, absolutely.  04:17 - Tom (Guest) It's interesting because the prism that most people look through all awards through is the Oscars. Right, and it's like Billy Crystal said it's an evening for three hours where millionaires are handing each other gold statues, which is pretty funny and accurate. But here's the thing I just realized about all this is that if you are a member of the Academy the Film Academy and you get your screeners, you know that Daniel Day-Lewis is up for best actor and you're watching the movie, or whatever excerpts of the movie that they sent you for you to cast your vote for him or somebody else.  04:50 - Anne (Host) Right or anybody else in any other category, or if you're not a voter right, you're a person going. Oh, hmm, somebody thinks that movie's credible, maybe I'll go see it. Guess what that resulted in Purchasing right, purchasing right, purchasing a ticket to go see that movie. So marketing, it worked, so marketing.  05:05 - Tom (Guest) But here's the interesting Anne that I just realized when it comes to the One Voice Awards which we both got, I got nominated for a little one, just one, yay, congratulations.  05:13 - Anne (Host) Tom Dheere.  05:13 - Tom (Guest) The commercial category.  05:14 - Anne (Host) Oh, that's right. That's right, Tom, that's awesome.  05:25 - Tom (Guest) So for your performance, but it's really nice. It's just being like, hey. But here's the thing about it is that when you submit, it's my understanding that when they listen to these demos that you help produce or these voiceovers that I did, they don't know who they're listening to.  05:41 - Anne (Host) Yeah, theoretically.  05:43 - Tom (Guest) So it's theoretically, I mean.  05:44 - Anne (Host) In a closed industry. Sometimes, like I know Tom De're listening to yeah, theoretically, so it's theoretically, I mean In a closed industry. Sometimes, like I know Tom Dheere voice.  05:48 - Tom (Guest) Well, that's exactly what I was about to say. I would like if there were three or four or five, if there were five people who were listening to these, I think that maybe two or three of them would probably be like that's Tom.  05:58 - Anne (Host) Yeah, yeah, yeah, but they don't talk to one another.  06:01 - Tom (Guest) But they don't talk to one other so it's generally anonymous and it's generally done in isolation.  06:06 - Anne (Host) I can say that for certain because I've been a judge prior.  06:09 - Tom (Guest) Right, oh, okay, so.  06:10 - Anne (Host) I can say for certain that it is closed and that you do not know who the entry is. You don't know who submitted it, right, and it's isolated.  06:18 - Tom (Guest) So for the five lovely voice actors whose demos were nominated that you produced. They didn't know who they were and they didn't know that necessarily that it was you that produced it. I mean, after a while, if you listen to enough demos, you can be like that's a Chuck Duran demo, that's a Nancy Wolfson demo because there's just like styles, there's styles you know what I mean, but for the most part they're not going to know who these voice actors are, who are nominated for any of these or for the demo.  06:43 So I think it's more of a pure. There's a level of purity in it that there isn't in the Oscars, for example.  06:48 - Anne (Host) Yeah, there's a combination for that particular category of not just the demo but the performance in the demo and hopefully, if you have created that demo and produced that demo, that has lent itself to a wonderful performance. And just being nominated, I want to say to anybody out there, just being nominated is a win. It doesn't matter, honestly, if I win, and I've been entering awards for years now. There's been many, many years where I didn't win and so I have to like always talk to myself and talk to my students to make sure that if I don't win it doesn't mean that I'm not worthy, it doesn't mean that that nomination wasn't really a win, because you can still believe it or not, you can market a nomination just like a win.  07:28 - Tom (Guest) Absolutely, and the Oscars— it sounds pretty darn similar. The Oscars do it all the time.  07:32 - Anne (Host) Mm-hmm. Award-nominated versus award-winning.  07:35 - Tom (Guest) Right. Did you ever watch the Secret Life of Walter Mitty?  07:38 - Anne (Host) That's the one that Ben Affleck wrote, and directed and starred in.  07:42 - Tom (Guest) I thought that movie was exceptional and I swore I was going to get all these nominations. It didn't get a one.  07:48 - Anne (Host) And.  07:49 - Tom (Guest) I don't know if it's because they didn't think it was off to snuff, if it was too past the deadline, or if they just chose not to submit it, because that's the other thing. We choose to submit ourselves for these awards. Now for actors in Broadway and television and film. They have their production companies or networks or whatever deciding to do these. Oh, we think these people have the best chance and they still have to pay submission fees as well, application fees for the nominations, just like any other nomination, which I think is-.  08:16 - Anne (Host) Well, there's a cost to running an award show. There's a cost to having people judge the awards. There's a cost for people's time, absolutely. So paying to enter yourself into an awards is. I don't find anything necessarily wrong about that.  08:33 - Speaker 2 (Announcement) No.  08:33 - Tom (Guest) Maybe how much you pay, I don't know I mean if it's a for-profit scheme, then you know, okay, I mean people who organize awards. Should they or do they deserve to make a profit, Like I don't know if, like the Oscars, if that's a nonprofit situation where they don't make any money off of it, they just want to celebrate the industry and recognize people for it, and they don't make a dime. And they make the fees just enough to cover the cost to produce the show and print and, you know, make the gold statues.  08:59 - Anne (Host) Well, it becomes a marketing effort for the venue. It becomes a marketing effort for the people who put stuff in the swag bags. It becomes a marketing effort for so many things really. And it's like it's not always obvious, but in reality it really does lend itself to marketing quite a bit.  09:17 - Tom (Guest) One of the other questions. One of the anti-award swath of the voiceover industry says winning award isn't going to book you more work. And for the Oscars? We know that's not true, because when actors or actresses win an Oscar, they get a lot more scripts on their desk. They've all said that they just get more acting opportunities. So in that context it's 100% true. Is it true for voice actors? I'd say it probably isn't, because your typical explainer video production company has never heard of the One Voice Awards. But that's not the reason that you do it. But yeah.  09:52 - Anne (Host) However, let's just go beyond it, because if you market yourself as an award-nominated voice actor or an award-winning voice actor, right, if somebody happens to find you or find your website, right, it lends some credibility. I believe it lends some credibility to who you are. So if I'm a person and I don't know the voices and I have two equal voices that I like if I see that one has won an award or has a history of winning awards or being nominated for awards, I'm going to feel like, oh, maybe they've been in business a little bit longer, maybe they're considered by others to be top of their field, and so I would maybe sway toward an award nominated or award winning. And again, it really depends on how people, given equal circumstances, award winning, award nominated versus maybe not.  10:42 - Tom (Guest) I think that's a very fair point. Now, where my mind was going where Tom Dheere, the VO strategist, business and marketing guy, was going is what's the SEO value of?  10:53 - Anne (Host) the terms award-winning.  10:55 - Speaker 2 (Announcement) Like how is that what's the?  10:56 - Tom (Guest) score. Yeah, what's the keyword score? You know what I mean. So actually, I want to make a note of that. I want to look that up when we get off of this.  11:03 - Anne (Host) I'll tell you, when I look for a company to purchase from right, what's the criteria? I want to make sure that that company's been in business for a while. I want to make sure that they put out a quality product and I want to know that there's testimonials of other people who have used that product that are actually saying yes, it helped me, it was wonderful, it was quick and painless. And think about that. This could be right. Anybody who might have won an award and has testimonials on their website. Right, If you've award winning, then that gives it a little bit of credibility that maybe other people have listened to this person. They're definitely a professional in the industry, right? You don't submit for an award unless you're a professional, so sometimes you just don't know who you're working with. It can help people, I think, to get to know you a little bit better, or really, I think, put that credibility forward first when people are making a buying decision.  11:58 - Tom (Guest) Yeah, I mean, and now that I'm thinking about it as we're talking about it, what's a better testimonial than an award nomination? Right, yeah, I mean, and now that I'm thinking about it as we're talking about it, what's a better testimonial than an award nomination?  12:04 - Anne (Host) Right, yeah, I mean really.  12:06 - Tom (Guest) Right, what's a better endorsement?  12:07 - Anne (Host) That was kind of my point right, it's a wonderful way. So if I buy because of they've been in business, they're not going to just go out of business and take my money and steal it. They're credible, right? They have a good product, right? Well, if they're award nominated, award-winning, that lends me to think that when I look for a beauty product, hello, I'm going to go back to you know award-winning award-winning formulas.  12:28 If I have no knowledge whatsoever of the product, right, I'm going to tend to look there first and after I look there, right, I'm going to look for it. Actually, if I do my shopping on Amazon or I do shopping on anything, right, I'm looking for the number of stars, the ratings, right, A lot of times they go hand in hand. Right Ratings and reviews.  12:46 Ratings and reviews and so award nominated best beauty product of 2024 by Elle magazine, that kind of thing. That kind of means something to me. I'm like, well, somebody did their research right and so therefore, if it's talking about a voice talent that's award-nominated and award-winning, I would feel like, oh okay, maybe there's some credibility there. Now I can go ahead and listen. Let me listen to the voice and see if it's something that I want.  13:10 - Tom (Guest) Yeah, yeah. And of course the capitalist in me thinks oh and if you're an award-winning voice actor, maybe you can charge more.  13:18 - Anne (Host) Well, I right, that's very true, but I also know like if people come to me for a demo, right, they're like I want to win an award. I always try to say to them well, that shouldn't be like I really have people say that to me.  13:28 That shouldn't be the goal. However, they're like I want an award-winning demo. What are they saying to me? They're saying to me that they want the absolute best demo that is valued by the community or valued by others in the community. So they want a valuable product. That's what they're saying to me and I'll kind of say, well, okay, I don't design demos to win an award. However, I want to design a demo to get you work right and if it wins an award, that's a great bonus. And they're like yeah, I know, but I still want an award winning right? People will say that to me, so it's kind of human nature, I think, to want to lean toward a product that is award-winning.  14:05 - Tom (Guest) Right, Because nobody says I want to eat something that's been not approved by the FDA. Yeah right, Exactly, I will never. I will eat at no restaurant that's ever won a Michelin star. I refuse, it's like no, that's ridiculous.  14:17 - Anne (Host) Because it's not just the recognition, it's what the recognition represents. Yeah, absolutely, absolutely so. For me that's where the awards have always sat and I did have issues for years until I explained to my students who I said I think you should enter this into the awards. I will always say, hey look, I think it's an award worthy product, right. And so they're like oh really, and that gives them like a sense of worth or a sense of like pride. Hopefully I wouldn't say it if I didn't think it had a chance of getting some recognition.  14:52 So if I say that to someone, then I've given them a sense of accomplishment, I'm giving them confidence in their product so that they can then represent themselves and sell it better, and that's basically how that'll work. But I will always explain to them look, if you do not win, remember awards are very, very subjective. There have been some amazing, just like there have been some amazing movies that didn't win the best picture of the year. There have been some amazing actors that have not won best actor or best actress, and so you know, you have to really make yourself aware, even though in your heart you might be disappointed if you don't win right or don't get nominated. But you do have to realize that it is very, very subjective especially if you've got an award show that it doesn't cost anything to enter. Nothing ventured, nothing gained. You're not losing out on anything really by submitting.  15:46 - Tom (Guest) I mean, take a chance. It's like playing the lottery, right. Take a chance, Absolutely. So, with all that in mind, what do you do from a marketing stance? And I've got my own ideas too, about how we could tell VO bosses. You've got a thing, whether it's a spot that I did for a college or if there's a demo that you produce with a student.  15:59 - Anne (Host) What are the?  16:00 - Tom (Guest) steps to use it, to use the award, nomination and hopefully the win, as a marketing tool.  16:05 - Anne (Host) Well, absolutely put it on your website right.  16:08 Absolutely throw it on YouTube, put it on your website. Label it as being award nominated, award winning, like. Make sure the text is in there, because that's SEO value. Make sure that it's on your website, make sure that it's on every single profile, make sure that it's in every single description, make sure that it's literally like SEO optimized. And then make sure that wherever you're describing it as an award nominated, right, award winning entry or whatever that might be, make sure that you're also giving information about the industry that you're in best performance voice actor, corporate narration, right or whatever, or best performance demo, reel, animation so it then allocates the other words that are important. So when people are searching for animation, voice, right and then all of a sudden, this will come up, as I'm so excited that my award-winning entry or award-nominated entry or whatever if something comes up or shows up in their search, that's going to lend its credibility and also hopefully lead to your website so that they can then inquire further or get an audition from you or find out more and contact you.  17:14 - Tom (Guest) Yes, I'll layer on top of that, like, for example, when I found out I got my One Voice nomination, I wrote a blog about it.  17:22 - Anne (Host) Yep, that's wonderful.  17:24 - Tom (Guest) So what that does is a number of things. Every time that you write a blog, you publish a blog, it adds another page to your website and All of the content on that particular website is saying voice over, this voice acting, that voice talent, this voice artist, that. So it's got all of the keywords that would further enrich the search engine optimization of your website, to make it more searchable and for it to rank higher. So just writing about it is extremely important on a technical SEO level. However, you don't want to turn it into a self-aggrandizing. Oh, look at me. It could be about a number of things.  18:05 - Anne (Host) It could be about the company that created the one voice in this situation, or about the company that you voiced for.  18:11 - Tom (Guest) Or about the company that you voiced for exactly. So a couple years ago I got a one voice nomination for a public service announcement I did for the Humane Society. Remember those 4,000 beagles were rescued from a lab in Virginia. A few years ago.  18:25 And then the American Humane Society got all 4,000 beagles adopted. So I auditioned and booked the voiceover for the public service announcement announcing that all 4,000 beagles were adopted. So when I blogged a few years ago back then about hey, I got this award nomination, it wasn't about the award, it wasn't about the nomination, it wasn't about me, it was about bringing awareness, it was about the beagle puppies. That's what it was about. I made it about the puppies.  18:53 - Anne (Host) And that's wonderful, because what's a better draw than animals, your fur babies, right?  18:59 - Tom (Guest) Yes.  19:02 - Anne (Host) Which is I lead all my award nominations with my cats there you go.  19:04 But that's an actual great idea, like somehow, let's just say, my Bengal Manx mix Sebastian, who everybody's gotten to know because they have their own Facebook and Instagram and TikTok right. So we could just say, oh, they're in my studio listening and then all of a sudden you can silently incorporate or just in the back end, incorporate that performance or that particular working on a demo for blah blah, blah blah blah For me on my website, because I advertise that I do demo production. Under the demo page, the landing page, I have all the awards and nominations that I've ever done and received, and for the VO Boss, because we've won awards for the VO Boss podcast and nominations. I also have it on my VO Boss website as well, as well as writing a blog on VO Boss about it. So absolutely trying to garner an award-winning podcast.  19:49 - Tom (Guest) Yeah, the other thing that I do is I make sure that I reached out to the production company that cast me for it, so my nomination this time was for North Idaho. College just a real tiny, tiny little postage stamp-sized college in the Northwest of our country and that one got nominated and it's a great. It's a great ad. It's beautifully shot, the editing is just superb. The music is perfect. You know, I'm probably the worst thing about the whole thing.  20:16 - Anne (Host) I love how generous you are. I think that's the way you need to approach it. They could just break apart and say it's your voice, but in reality, when you're presenting a product or a piece for an award, it's the whole darn shebang. If you think about it, that helps with that presentation. It's the media, the music behind it, the voice. It's all like a beautiful symphony in reality.  20:36 And so paying it forward and having gratitude for the other parts of it that helped you to win that award or that nomination, I think is a wonderful way to not appear to make it like a vanity thing, because you're showing appreciation for all of the components that help make it happen. I mean, whenever I make an announcement by the way, the other thing that I do to market is on social media, right so I'm highlighting the demo clients of mine that their voice has been nominated, and I'm also giving thanks to my audio engineer and in reality, it's like I could not have done it without you, to be quite honest, and so that then lends it to be a little less vanity ridden or sounding, I should say.  21:16 - Tom (Guest) Right, I mean in the Oscar Awards, do they go up there, accept the award, thank themselves and then get off the stage?  21:21 - Anne (Host) No, they're always thanking the people that helped them make it possible, really Exactly Also just from a technical and SEO perspective.  21:28 - Tom (Guest) Another reason why I like to let the production company know is because now they have the opportunity to use this nomination as marketing fodder for their own campaigns on their website and social media and newsletters and things like that.  21:43 So it's just paying it forward also on a marketing level. So the production company just has because all the voice seekers are as desperate to come up with quality content to put on their website and social media and their communications as us voice actors are. So to give them saying, hey, here's a free nugget of marketing gold that you can go do something with it helps everybody.  22:05 - Anne (Host) Absolutely. I actually got a statue. I got one of the awards for one of my partners on the podcast and shipped it. When I won this podcast I'm trying to think a couple years ago I also ordered an award for the person that I interviewed on that show and I shipped it, and that was actually for Alex Srdjak from Respeecher, so I shipped it to. Ukraine.  22:27 So I literally and that's how grateful I was. And it was really cool because when he received it, of course, what did he do? He took a picture of it with him, right, and then he used it for his own marketing, which I thought was really wonderful. So it kind of was like it all works for everybody involved.  22:42 - Tom (Guest) See, haters. There are so many great things about a voiceover award nomination and a win. There's so many great things that you can do, not just for yourself, but for the people that made the nomination possible.  22:53 - Anne (Host) Absolutely. You know what do you say to the haters? I mean you don't have to enter and you don't have to watch. I mean you don't have to enter and you don't have to watch awards and you don't have to participate. If you don't agree with it, that's completely fine. It's completely fine in reality, but for those that do, there's value to it beyond the award. Really, it's beyond the award and, like I said, even if you don't get nominated, if your coach or somebody says you should submit that for an award, consider that a win. Really. If you have a colleague that listens to this and say, oh my God, that was amazing, you should submit that. Right, there is an award for confidence, for somebody believing in you and believing in your work and thinking that it is worthy of an award, and that, to me, is a win right there.  23:36 - Tom (Guest) Absolutely.  23:37 - Anne (Host) So good stuff. Tom Dheere, Congrats on your noms.  23:42 - Tom (Guest) Congrats on your noms.  23:43 - Anne (Host) Yeah, thank you. And bosses out there, utilize this for good, for marketing efforts. And even if you just want to submit your work to your colleague and say, what do you think right, consider that your award submission for a job well done. And if you don't win, don't let it affect you. It has nothing to do with your worthiness, with your performance. It basically is something that you know. What if you don't win, try, try again. What is it If you don't?  24:09 - Tom (Guest) If at first you don't succeed try, try again.  24:12 - Anne (Host) Well, yeah, well, if you don't win, try, try again. That's what I say. I always think there's something good in a little bit of competition, right? That keeps us motivated and keeps us inspired to want to be better and do better. So allow that to help you further your career. So, whether or not you win an award, allow it to inspire and motivate you. So good stuff. All right, Tom, thank you so much. I'm gonna give a great big shout out to our sponsor, ipdtl. You too can connect and be award-winning bosses. Find out more at IPDTLcom. Tom, thank you so much, and bosses have an amazing week.  24:54 - Speaker 2 (Announcement) We'll see you next time. Bye, join us next week for another edition of VO Boss with your host, Anne Ganguzza, and take your business to the next level. Sign up for our mailing list at vobosscom and receive exclusive content, industry revolutionizing tips and strategies and new ways to rock your business like a boss. Redistribution, with permission. Coast to coast connectivity via ipdtl.   

Minimally invasive, patient-centered, and globally disruptive — is this is the future of breast aesthetics?In this episode of The Technology of Beauty, Dr. Grant Stevens welcomes Roz Cole d'Incelli, a veteran of the breast implant industry and current Senior VP at Motiva, for a revealing look at the past, present, and future of implant innovation. From her early days at McGhan and Mentor to her pivotal role at Sientra and now Motiva, Roz shares a career built on driving meaningful, science-based change in women's health.This episode unpacks how Motiva's new FDA-cleared implants and next-generation technologies—like the Mia injectable implant—are revolutionizing the aesthetic space. Roz explains how Motiva is leading the charge in creating safer, more natural-looking results through advanced gel-shell integration, unique surface technology, and preservation-based surgical tools.You'll also hear about Motiva's global impact, from surgical missions to innovation pipelines in gluteal augmentation and beyond. Tune in to learn how Motiva is reshaping the conversation around breast surgery.» Apple Podcasts | https://podcasts.apple.com/us/podcast/technology-of-beauty/id1510898426» Spotify | https://open.spotify.com/show/0hEIiwccpZUUHuMhlyCOAm» Recent episodes | https://www.influxmarketing.com/technology-of-beauty/» Instagram | https://www.instagram.com/thetechnologyofbeauty/» LinkedIn | https://www.linkedin.com/company/the-technology-of-beauty/The Technology of Beauty is produced by Influx Marketing, The Digital Agency for Aesthetic Practices. https://www.influxmarketing.com/Want more aesthetic insights? Subscribe to Next Level Practices, the show where we discuss the ever-changing world of digital marketing and patient acquisition and bring you the latest ideas, strategies, and tactics to help you take your practice to the next level. https://www.influxmarketing.com/next-level-practices/

Last week's public disclosure that a gene therapy from Sarepta had caused a third death led FDA to ask the company to stop distributing its DMD gene therapy Elevidys, a move the biotech has resisted. The deaths, and disputes between FDA and Sarepta, raise questions about the future of AAV gene therapies, as well as the future of FDA's platform technology designation. On the latest BioCentury This Week podcast, BioCentury's analysts unpack the events surrounding Sarepta's gene therapies and discuss how FDA, industry and patient groups should come together to learn the lessons from the tragic, avoidable deaths.BioCentury's analysts also assess Monday's appointment of Stanford professor and biotech executive George Tidmarsh to lead FDA's Center for Drug Evaluation and Research, and check in on the latest trends in venture financings. This episode of BioCentury This Week is sponsored by IQVIA Biotech.View full story: https://www.biocentury.com/article/656537#biotech #biopharma #pharma #lifescience #GeneTherapy #AAVTherapy #Sarepta #Elevidys00:01 - Sponsor Message: IQVIA Biotech02:03 - Gene Therapy17:59 - Leading CDER27:00 - Venture ReportTo submit a question to BioCentury's editors, email the BioCentury This Week team at podcasts@biocentury.com.Reach us by sending a text

Google riding high ahead of earnings, with potential for its longest win streak in years. Japan's election results have the Yen strengthening against the dollar. And Sarepta's slide continues as the drug developer rebukes the FDA's request to halt shipments of its gene therapy drug. Why one Wall Street analyst says the stock could head to zero. Fast Money Disclaimer  

More people over the age of 50 are being diagnosed with MS than ever before. When you consider the other health conditions that often develop as we age, and you add the fact that our immune system changes with age, there's a lot to think about when it comes to diagnosing and treating late-onset MS.   This week, Dr. Jacqueline Nicholas, the System Chief of Neuroimmunology and Multiple Sclerosis at the OhioHealth Multiple Sclerosis Center, joins me to help us better understand late-onset MS. We'll also tell you about research results that could lead to a simple blood test that can predict MS years before someone experiences a single symptom. You'll learn about an ultra-high resolution brain imaging tool that could open the door to precision neuroscience and revolutionize the treatment of neurological disorders The FDA wants to talk with people about what living with MS is like, and what they're looking for in future treatments. We'll tell you how and where to register for an informational webinar that will give you all the details about the Shaping Tomorrow Together initiative. And if you're in or around Northern California, we'll remind you that you can join us this Saturday in Napa Valley at Crush MS! We have a lot to talk about! Are you ready for RealTalk MS??! This Week: Understanding Late-Onset MS  :22 How a simple blood test may predict MS years before someone experiences any symptoms  1:34 How a new ultra-high resolution brain imaging tool may revolutionize the treatment of neurological disorders  6:40 Are you interested in telling the FDA what it's like living with MS, and what you want in future treatments?   8:53 Are you ready to support MS research while spending the afternoon in a Napa Valley vineyard? Get all the details to attend Crush MS  10:29 Dr. Jacqueline Nicholas discusses what's different and what's the same in treating late-onset MS  12:09 Share this episode  29:26 Have you downloaded the free RealTalk MS app?  29:46 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/412 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com Become an MS Activist https://nationalmssociety.org/advocacy STUDY: Early Identification of Individuals at Risk for Developing Multiple Sclerosis by Quantification of EBNA-1-381-452-Specific Antibody Titers https://nature.com/articles/s41467-025-61751-9 REGISTER: Informational Webinar on the FDA "Shaping Tomorrow Together" Listening Session https://nmss.zoom.us/webinar/register/WN_hHdHhEE3TBmPJ2glcgME0Q#/registration EVENT: Crush MS https://crushms.org Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 412 Guest: Dr. Jacqueline Nicholas Privacy Policy

AI-boost for mammograms—a bridge too far? Plastics and heart disease; What does a high CRP mean? Social media marketing of female aphrodisiac dinged with FDA warning; Roundup gets a makeover; Artificial sweeteners may hasten puberty in kids; Plus an encore of our interview with Dr. Jeffrey Bland introducing Himalayan Tartary Buckwheat as a hedge against age-related immune decline.

On July 17, the FDA announced that Juul Labs products are authorized in the market. However, the vape market still has very little clarity, and that was the focus of a July 18 letter from NACS and other groups to President Trump asking for action. Hosted by: Jeff Lenard About our Guest: Doug Kantor, NACS General Counsel Doug has served as legal counsel for NACS for more than 20 years, originally as a partner with the law firms Collier Shannon Scott PLLC and Steptoe & Johnson LLP. He has been NACS in-house counsel since 2021. Doug also served as special counsel and deputy chief of staff in the U.S. Department of Housing and Urban Development.

In this insightful episode, Mike Drues joins host Etienne Nichols to dissect the FDA's most frequently cited compliance issues, challenging the notion that many are strictly "pre-market" concerns. They delve into the nuances of software changes, design creep, and off-label marketing, providing a critical look at how companies can avoid common pitfalls. This discussion is vital for MedTech professionals seeking to understand the true nature of FDA expectations and build more robust quality systems.Timestamps00:04 – Introduction to common FDA compliance issues02:02 – Discussion on FDA's policy of not naming individuals05:45 – Mike Drues challenges the "pre-market" classification of common issues09:20 – Documentation requirements for different device classes11:35 – Mike's take on the most common FDA issues (beyond the presented three)15:40 – Root causes of common compliance problems and industry responsibility20:00 – The role of regulation and FDA's responsibility in clarity27:05 – Deep dive into design change and design creep31:40 – Software changes and the "bug fix" mentality35:45 – Marketing beyond authorized intended use with a real-world example41:00 – Key takeaways and proactive compliance strategiesStandout Quotes"If the regulation makes sense, we shouldn't need it. If the regulation doesn't make sense, we shouldn't have it." — Mike Drues. This quote encapsulates Mike's philosophy on regulatory compliance, emphasizing that true professionalism means understanding inherent needs rather than just following rules."You have a piece of software, you have a bug, you fix the bug… Is your job done? Absolutely not." — Mike Drues. This highlights a critical oversight in software development within MedTech, stressing the importance of holistic post-fix validation to prevent unintended consequences.Top TakeawaysRegulatory Misclassification: Many issues labeled by the FDA as "pre-market" (e.g., marketing beyond intended use, design creep) are fundamentally post-market compliance challenges. This distinction is crucial for companies to allocate resources effectively.Beyond Administrative Review: While administrative incompleteness accounts for a significant portion of 510(k) rejections (around 38%), the scientific and substantial equivalence reviews are major hurdles, with approximately 75% of 510(k)s rejected initially, primarily due to lack of substantial equivalence (85% of those rejections).Top Post-Market Violations: Historically, the most common reasons for FDA 483s and Warning Letters relate to CAPAs (12.5%), design controls (12.5%), and complaint handling (10.5%), collectively accounting for roughly 35% of all post-market issues. Companies should prioritize these areas.Software Change Management: Fixing a software bug is only the first step; a holistic review is essential to ensure no new problems are introduced and the device's safety, efficacy, and usability remain uncompromised.Intentionality vs. Compliance: Marketing a device beyond its authorized intended use, even if the device functionally performs beyond its cleared claims, carries significant regulatory and product liability risks. Companies should seek appropriate clearance for expanded claims rather than relying on off-label promotion.References & LinksEtienne Nichols' LinkedInGreenlight GuruCall to...

Step into a peaceful sanctuary of sound. This ambient track features a gentle waterfall, subtle meditation layers, and birdsong to soothe your mind and body. Designed for deep rest, sleep, relaxation, or mindful moments, this nature-based soundscape invites you to disconnect from the outside world and drift inward.   Perfect for unwinding, meditating, background ambience, or bedtime listening.   If this helped you rest or relax, please consider following, sharing, or rating the podcast to support independent creation.   Download the Your Sleep Guru app for exclusive soundscapes, guided meditations, and immersive nature journeys:

CBP just announced that now all FDA-regulated products must be submitted with appropriate data sets regardless of de minimis value. With increased global reciprocal tariffs potentially around the corner, could this signal a broader de minimis prohibition?

Dr. Jonathan Howard and Wendy Orent unpack the ongoing collapse of trust in America's public health institutions, focusing on how FDA leaders Marty McCarey and Vinay Prasad weaponized vaccine myocarditis to undermine COVID vaccination efforts. With pediatric illnesses rising and the agency under fire from both scientists and extremists, this episode reveals how selective concern and ideological doublespeak are fueling a dangerous breakdown in science-based policy. It's a sobering look at the cost of playing politics with public health.   Connect with us further on https://sciencebasedmedicine.org/author/jonathanhoward/  The Fine Print The content presented in the "We Want Them Infected" Podcast and associated book is intended for informational and educational purposes only.    The views and opinions expressed by the speakers, hosts, and guests on the podcast do not necessarily reflect the views of the creators, producers, or distributors. The information provided in this podcast should not be considered as a substitute for professional medical, scientific, or legal advice. Listeners and readers are encouraged to consult with relevant experts and authorities for specific guidance and information.   The creators of the podcast and book have made reasonable efforts to ensure that the information provided is accurate and up to date. However, as the field of medical science and the understanding of the COVID-19 pandemic continue to evolve, there may be new developments and insights that are not covered in this content.   The creators are not responsible for any errors or omissions in the content or for any actions taken based on the information provided. They disclaim any liability for any loss, injury, or damage incurred by individuals who rely on the content.   Listeners and readers are urged to use their judgment and conduct their own research when interpreting the information presented in the "We Want Them Infected" podcast and book. It is essential to stay informed about the latest updates, guidelines, and recommendations related to COVID-19 and vaccination from reputable sources, such as government health agencies and medical professionals. By accessing and using the content, you acknowledge and accept the terms of this disclaimer.   Please consult with appropriate experts and authorities for specific guidance on matters related to health, science, and the COVID-19 pandemic.

What happens when half-priced Ozempic suddenly disappears faster than a donut at a dietconvention? The FDA just pulled the plug on compounded GLP-1 drugs, leaving millions scramblingto choose between $1,300/month prescriptions and back-alley “discounts” riskier than a gas stationsushi platter. Dive into the chaos: patients like Michelle facing spine surgery relapses, Big Pharma'slegal smackdowns, and why docs compare off-brand meds to “pancreas malware.” But don't panicyet—we've got your survival playbook, plus a wildcard solution involving beer's bitter cousin. Stickaround to discover how Calocurb—a hop-based supplement—might outsmart hunger hormoneswithout needles or shady pharmacies. Your next craving killer could grow in a field, not a lab.Special Guest: Sarah Kennedy – CEO of Calocurb, a natural GLP-1 activator

On this episode of Vitality Radio, Jared welcomes back naturopathic physician Dr. Lexi Loch from Terry Naturally to uncover two of the most powerful herbs in natural medicine: Boswellia and Curcumin (from Turmeric). While many are familiar with turmeric for inflammation, few realize that Boswellia (also known as frankincense) targets a completely different inflammatory pathway—one that traditional NSAIDs and pain relievers don't touch. Together, these herbs form a potent, well-researched duo for addressing pain and inflammation in the gut, joints, lungs, and beyond. You'll learn about the unique pathway that Boswellia modulates, the advantages of this unique curcumin extract over conventional turmeric extracts, and how combining the two offers faster and longer-lasting support. Whether you're struggling with IBS, asthma, joint pain, or simply want to manage everyday inflammation more naturally, this episode provides evidence-based insight and practical guidance you can trust.Products:Terry Naturally Boswellia & Curcumin ProductsAdditional Information:#524: Maximum Absorption of Nutrients for Energy, Pain, Immune, and Respiratory Challenges with Dr. Lexi LochVisit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.

Are you ready to uncover the hidden benefits of testosterone for women? Why is this hormone, often associated with men, crucial for women's health? Join us as we examine the surprising ways testosterone can protect against breast cancer, enhance cognition, and boost heart health with Christine Farrell, a renowned specialist in hormonal imbalances. How does testosterone therapy change the game for women navigating perimenopause? Discover the transformative power of testosterone pellets and learn about their potential to reduce breast cancer recurrence. Is testosterone actually capable of shrinking tumors? Ever wondered how personalized hormone therapy can optimize your well-being? What role does genetic testing play in crafting the perfect treatment plan? We explore these topics and more, revealing the profound impact testosterone can have on bone density, recovery, and cardiovascular health. In this episode, we uncover: How testosterone may protect against breast cancer and improve cognitive function. Why there are zero FDA-approved testosterone therapies for women in the US. The impact of testosterone therapy on migraines, chronic fatigue, and fibromyalgia. Why personalized approaches and genetic testing are crucial in hormone therapy. How testosterone therapy can improve cardiovascular health and bone density. Dig into the multifaceted benefits of testosterone for women's health. Join us on this enlightening journey and empower yourself with knowledge about hormone therapy options!     Sponsors Timeline is offering 20% off your first order of Mitopure. Go to timeline.com/HORMONE20 use coupon HORMONE20 and get 20% off your order. Get 10% off Massyzmes By BiOptimzers products at bioptimizers.com/hormone with coupon code HORMONE .     Are you in peri or post menopause and looking to optimize your hormones and health? At Hormone Solutions, we offer telemedicine services and can prescribe in every U.S. state, as well as in British Columbia, Alberta, and Ontario in Canada.   Visit karenmartel.com to explore our comprehensive programs: Bioidentical Hormone Replacement Therapy Individualized Weight Loss Programs  Peptide Therapy for weight loss    Interested in our NEW Peptide Weight Loss Program? Join today and get all the details here.   Join our Women's Peri and Post Menopause Group Coaching Program, OnTrack, TODAY!   To our nursing audience members, our podcasts qualify for nursing CE @ RNegade.pro. Provide # CEP17654.   Your host: Karen Martel Certified Hormone Specialist, Transformational Nutrition Coach, & Weight Loss Expert   Karen's Facebook Karen's Instagram

Wind rises over distant waves. Sleet cuts through the silence. This ambient track offers a cold, spacious environment to support deep rest, reflection, or meditation.   Layered natural textures create a sense of solitude and movement — ideal for sleep or moments when the mind needs quiet.  

On this episode of Vitality Radio, Jared launches a brand-new series celebrating time-tested natural remedies that are as relevant today as they were generations ago. “Grandma Was Right” kicks off with an exploration of one of the oldest and most iconic natural tonics: apple cider vinegar (ACV). Jared breaks down what makes ACV so powerful, from its centuries-old use for digestion and energy to its modern applications in blood sugar balance, kidney support, gallbladder health, and even muscle cramp relief. You'll learn about the science behind the “mother,” the difference between capsules, liquids, and gummies, and why vinegar might just be the most underestimated staple in your wellness cabinet. He also shares personal experiences and pro tips for using ACV effectively, especially if you're managing reflux, metabolic issues, or biliary sluggishness. If you've dismissed apple cider vinegar as just another health trend, this episode might change your mind—and your daily routine.Products:Vitality Nutrition Apple Cider Vinegar CapsulesZhou Apple Cider Vinegar Gummiesinner-eco Coconut Vinegar Gummies with ACVRoots & Leaves Fire CiderOld Amish Formulas for Reflux and Leg CrampsDynamic Health Apple Cider Vinegar - in store only Visit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Sernova has a new partner and a new drug for cell transplants, at home glucose/T1D test research, study looks at best diet for people with type 2, Lifescan files for banktrupcy, T1D Barbie and more! Find out more about Moms' Night Out  Read Hangy Woman's take on Barbie (and send me yours!)  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: In the News July 18   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Sernova is partnering with Eledon Pharmaceuticals to test a new immunosuppressive drug in its ongoing clinical trial for people with type 1 diabetes (T1D). The drug called tegoprubart is designed to protect transplanted islet cells without harsh side effects. The current treatment is known for its potential toxicity, especially towards insulin-producing beta cells, and its adverse side effects, making it less than ideal for islet cell therapy in T1D. Tegoprubart has already shown promise in earlier trials, helping T1D patients achieve insulin independence with better graft survival and fewer side effects. This next phase of Sernova's trial (Cohort C) will combine Eledon's drug with Sernova's Cell Pouch, an implantable device that houses insulin-producing cells. In earlier phases, six participants stopped needing insulin completely, with results lasting years. Sernova also plans to use stem cell-derived islet-like clusters from partner Evotec to create a next-gen therapy. If all goes well, a new clinical program could launch in 2026.   https://www.streetwisereports.com/article/2025/07/15/biotech-partnership-to-revolutionize-diabetes-treatment.html XX Researchers at Yale School of Medicine, funded by Breakthrough T1D, are evaluating GTT@home, a new finger-prick, at-home glucose tolerance test, to monitor early-stage type 1 diabetes (T1D) in individuals with T1D autoantibodies. Developed by Digostics (Dih-jos-tiks), the test offers a simpler, less invasive alternative to clinic-based oral glucose tolerance tests. The study aims to assess its accuracy, usability, and acceptance, potentially paving the way for wider use in early T1D detection and monitoring. The results of the trial will inform future regulatory submissions for GTT@home use in T1D, which already has regulatory approval in the UK, Europe and other regions for other types of diabetes. https://finance.yahoo.com/news/digostics-announces-university-trial-home-164300142.html XX LifeScan announced that it entered into a restructuring support agreement and, to implement it, filed for chapter 11 bankruptcy. As the process moves forward, LifeScan plans to operate in the ordinary course of business. It expects to emerge from chapter 11 by the end of the year. LifeScan develops the OneTouch Bluetooth-connected blood glucose meter and mobile diabetes app that provide simplicity, accuracy and trust in diabetes management. XX New study looks at quality of life and cost of AID systems. This was done in Finland which has the highest prevalence of T1D in the world. The results show automated insulin delivery pumps significantly improved quality of life and reduced diabetes-related complications. The quality-adjusted life expectancy increased by an average of 2.3 years for individuals using an automated insulin delivery pump. Although the overall costs of automated insulin delivery pump treatment were higher than those of conventional insulin pump treatment, its cost-effectiveness ratio was well below the generally accepted willingness-to-pay threshold of 50,000 euros in Finland. This is the first cost-effectiveness study of automated insulin delivery pumps conducted in Finland. https://medicalxpress.com/news/2025-07-automated-insulin-delivery-effective-treatment.html XX Blue Circle Health expands into the 11th state: Louisiana! This is Free, comprehensive virtual clinical care, education, and support program for adults with type 1 diabetes In addition to serving adults with type 1 diabetes in Louisiana, our program is also active in Alabama, Mississippi, Florida, Missouri, Iowa, Ohio, Vermont, New Hampshire, Maine, and Delaware.  The program serves as an extension of participants' existing care teams and ensures continuity of care The organization hopes to inform new care models and policies that remove barriers to healthcare People with T1D over 18 years of age who speak English or Spanish are eligible to enroll. To sign up directly, refer a person living with T1D, or learn how you can partner with Blue Circle Health, visit www.bluecirclehealth.org. XX A new study comparing three popular diets—intermittent fasting, time-restricted eating, and continuous calorie cutting—found that all can help people with type 2 diabetes lose weight and lower blood sugar. But one diet stood out: the 5:2 intermittent fasting plan, where participants eat normally five days a week and restrict calories on two. It led to better results in fasting blood sugar, insulin response, and sticking with the plan. Although researchers identified improved HbA1c levels, and adverse events were similar across the three groups, the IER group showed greater advantages in reducing fasting blood glucose, improving insulin sensitivity, lowering triglycerides, and strengthening adherence to the dietary interventions. https://www.sciencedaily.com/releases/2025/07/250715043351.htm XX MIT students have developed an implantable device.. for use during emergency low blood sugars.   The new implant carries a reservoir of glucagon that can be stored under the skin and deployed during an emergency — with no injections needed.   The researchers showed that this device could also be used to deliver emergency doses of epinephrine, a drug that is used to treat heart attacks and can also prevent severe allergic reactions, including anaphylactic shock. The device contains a powdered form of glucagon and can be remotely triggered—either manually or automatically by a glucose monitor—to release the hormone when blood sugar drops too low. No word on next steps to make this commercially available.   https://news.mit.edu/2025/implantable-device-could-save-diabetes-patients-low-blood-sugar-0709 XX We've covered T1D1 before, this is an insulin calculator app – there's more to it than that.. it was created by 13 year old Drew who lives with type 1, but removed from the apps stores a few years ago, along with other non fda cleared apps. Drew who is now 18, Tells us they just submitted to the FDA and are optimistic about being reinstated. https://www.instagram.com/t1d1app/ XX   XX 1'm Brodie Sargent, a Type 1 diabetic raised in Mudgee, NSW, and currently living in Wollongong.   Starting August 26th, I'll be running a marathon every day for 26 days, and on the 27th day, I'll be finishing with Western Sydney's Half Ironman.   The current world record for the most consecutive marathons run by a Type 1 diabetic male is 25 and I'm aiming to break it.   I'm doing this to inspire others, diabetic or not, to challenge themselves and not let anything hold them back.   Any donation is greatly appreciated and supports a cause I truly believe in. The Type One Foundation focuses on support, connection, awareness, and advocacy for diabetics across Australia. They run online and in-person events for diabetics and their families, and also offer care packages to those newly diagnosed.   I was diagnosed at 15, and it was a tough time for me and my family, we had no history or understanding of diabetes. I was already a shy and awkward kid, and I struggled to speak up about how much it affected me. I started running with my roommate just to kill time but it quickly took over my life. Feeling stuck and unsure where I was heading, I decided to make a change and try to help anyone out there feeling the same way.   You can follow my journey on Instagram: @typerun_   XX Launched during children's congress To further promote inclusivity and tackle the stigma associated with the condition, Mattel partnered with Breakthrough T1D, a global organization dedicated to type 1 diabetes research and advocacy, to launch its first Barbie with type 1 diabetes. This partnership marks a major milestone in Mattel's commitment to greater representation, and highlights Breakthrough T1D's pivotal role in ensuring visibility for the type 1 diabetes community.   The doll is part of the Barbie Fashionistas line and includes key diabetes management tools modeled accurately with the help of Breakthrough T1D. The type 1 diabetes Barbie wears a continuous glucose monitor (CGM) secured with Barbie-pink, heart-shaped tape, and has an insulin pump at her waist. She also comes with a CGM-tracking smartphone, a pastel blue purse, and a blue polka dot outfit – blue being the color that symbolizes global diabetes awareness.   As part of a broader initiative to elevate voices in the type 1 diabetes community, Barbie also partnered with two global role models living with type 1 diabetes: Peloton Instructor Robin Arzón and model Lila Moss.   Robin Arzon Barbie Image Credit: Breakthrough T1D and Mattel Mattel's one-of-a-kind doll based on Arzón features her signature yellow outfit and a crown-shaped CGM on the back of her arm.   In interviews, Moss has highlighted the positive impact that the type 1 diabetes Barbie's visibility has already had, saying she receives daily messages from young people who feel less insecure about wearing their diabetes devices thanks to her public advocacy.   When Linxi Mytkolli, director of patient engagement at Diabetes Action Canada and person with diabetes, heard about the new “Dia Barbie,” she said she teared up.   “I grew up loving dolls, but I never saw one that reflected the reality I now live with – until Dia Barbie. Seeing a doll with a CGM, insulin pump, and even heart-shaped medical tape felt surreal. It's playful, powerful, and personal all at once,” said Mytkolli.   Mytkolli also emphasized that representation and visibility in toys and media can help chip away at shame.   “I've heard from so many people, especially those diagnosed in childhood, who delayed using tech like pumps or CGM because it felt like a punishment. Visibility in toys helps normalize these devices and makes kids feel like they're not alone or ‘othered.' It turns stigma into something softer – something that can be talked about, shared, even celebrated,” Mytkolli said.   And its impact goes beyond people living with diabetes. Laura Pavlakovich, who is the founder and CEO of You're Just My Type and has lived with type 1 diabetes since age five, shared that this representation is equally crucial for those without diabetes, as it demystifies the condition and challenges stereotypes.   “This kind of representation builds a vital bridge of empathy, illustrating that living with diabetes is simply a part of life for millions. It's an essential tool for educating the public and cultivating a more inclusive and supportive society for everyone,” said Pavlakovich.   Pavlakovich shared her personal experience of growing up with diabetes and how this will provide validation for those with the condition who often feel unseen.   “I vividly remember growing up with a 'my twin' doll, custom-made to look just like me, yet she always lacked the crucial part of my daily reality: an insulin pump. To finally see a Barbie, an iconic figure in childhood play, accurately depict someone living with type 1 diabetes, complete with her devices and pump, is truly a monumental moment,” said Pavlakovich.   To celebrate the launch, Barbie donated dolls to the Breakthrough T1D 2025 Children's Congress in Washington, D.C., where 170 young advocates for type 1 diabetes from around the world met with lawmakers to raise awareness. Priced at $10.99, the doll is now available on Mattel Shop and at retailers nationwide.   While this is a huge win for enhancing the representation of children living with diabetes, it doesn't end there. There is still significant work to be done to improve access to diabetes medication and technology.   “It is not lost on me that Barbie has more access to diabetes tech than many, if not most, people with diabetes globally,” said Mytkolli. “Representation and access – we deserve both.”   By bringing a common but misunderstood condition into children's toy boxes, the new type 1 diabetes Barbie is more than a toy. It's a symbol of pride, visibility, and the message that children with diabetes can live full, empowered lives.   As Mytkolli said, “Whether a child is living with diabetes, or loves someone who is, this doll quietly says, ‘You're not broken. You belong.'”

“The proteasome itself, it really helps us unfold or get rid of misfolded proteins or degradations of different cells. We used to have garbage disposals in our sinks, and we used to put food product in there. If your garbage disposal is clogged, then everything backs up. So that's kind of what's really going on in the cell itself, is that I'm building up these unnecessary proteins that we should be getting rid of, and it actually causes apoptosis or cell death,” ONS member Daniel Verina, DNP, RN, ACNP-BC, nurse practitioner for the multiple myeloma program at Mount Sinai Medical Center in New York, NY, told Lenise Taylor, MN, RN, AOCNS®, BMTCN®, oncology clinical specialist at ONS, during a conversation about the proteasome inhibitor drug class. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours (including 40 minutes of pharmacotherapeutic content) of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by July 18, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learner will report an increase in knowledge related to the use of proteasome inhibitors in the treatment of cancer. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ Pharmacology 101 series ONS Voice article: AI Multiple Myeloma Model Predicts Individual Risk, Outcomes, and Genomic Implications ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook (fourth edition) Guide to Cancer Immunotherapy (second edition) Multiple Myeloma: A Textbook for Nurses (third edition) Clinical Journal of Oncology Nursing article: Optimizing Transitions of Care in Multiple Myeloma Immunotherapy: Nurse Roles Oncology Nursing Forum articles: Changes in Health-Related Quality of Life During Multiple Myeloma Treatment: A Qualitative Interview Study Facilitators of Multiple Myeloma Treatment: A Qualitative Study ONS Guidelines™ and Symptom Interventions Adherence to Oral Anticancer Medication Peripheral neuropathy ONS Hematology, Cellular Therapy, and Stem Cell Transplantation Learning Library American Society of Hematology International Myeloma Foundation Leukemia and Lymphoma Society Multiple Myeloma Research Foundation To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “When we look at the administration, we also want to make sure that we're looking at the blood counts, right? Because proteasome inhibitors are well known for causing thrombocytopenia and neutropenia. So making sure that the patients do meet eligibility for the treatment for that day, and do they have anemia or lower red blood cell counts. You want to make sure that, because of these therapies, that the patient has no symptoms or infections going into each therapy for that day.” TS 10:19 “[Bortezomib], interesting enough, it can cause hypotension, cardiac failure, and sometimes pulmonary edema. Switching that up a little bit, what makes it slightly different, carfilzomib … a lot of times we saw, even in the clinical trial, that there was a lot of hypertension or cardiomyopathies, or arrythmias that we saw with carfilzomib and different dosages that they have indicated from the FDA. So again, monitoring the hypertension … or heart failure.” TS 15:16 “We also want to keep in mind another adverse effect, and especially in myeloma—our patients come in the door already immunocompromised just by the disease state alone. But now I'm giving them therapies that can drop their neutrophil count, so neutropenia and thrombocytopenia, so they are at a higher risk of having serious infections, even including like pneumonia or having outbreaks of herpes zoster or shingles.” TS 16:50 “If the patient has shortness of breath or symptoms, hold the therapy. I think that's one of my biggest messages when it comes to cancer treatments and educating other healthcare providers, or even educating our patients and their caregivers or the care partners with them, is that we need to sometimes hold the therapy for safety.” TS 22:02 “I say keep a log, keep a book. Let me know when the symptoms happen. Are they happening the day of treatment? Are they happening two days later from the treatment? Are they happening a week later from the treatment? And being able to kind of guide which therapy is causing some of these adverse events or side effects alone. So, making them have calendars. When did you take the drug, when did you get your last infusion or your last [subcutaneous] injection? Always talk to your care team, whether it's in the academic center or next to your house in the community.” TS 26:17 “It's us learning how to listen to the patient going forward. We have tasks to do—we all have tasks to do in our lives—but we have to take a breath, be mindful who's in front of us, listen to them first, and then be able to talk to them and care for them upfront and see what the symptoms are. I think that's what we need to do. We have to take a breath in cancer.” TS 39:35

Juul has received the green light from the FDA to keep selling its e-cigarettes, sparking a fresh wave of discussions in the vaping community. Meanwhile, an intriguing proposal from Trump and Bondi suggests that Alcatraz could re-emerge as a prison—talk about a twist in history! On another note, let's dive into the pressing challenges surrounding waste management that are affecting our communities today.

Indy FOP Calls Out City Council for their Lack of Action in Addressing Soft on Crime Prosecutor and Revolving Door. All of the sudden the left cares about the rural areas, Netflix is a juggernaut, FDA getting rid of outdated rules. What will Trump with Too Late Jerome Powell? CNN Panelist questions if Trump was actually shot. Is Jimmy Kimmel next? See omnystudio.com/listener for privacy information.

Rescission has passed. $9B is just a start, more is needed/ Probe of the autopen commences. We want the information. That makes us the bad people? Trump and his legs. Coldplay’s ‘kiss cam’ exposes apparent affair between mortified CEO and HR Chief. This story about Trump is insane, and I don't believe a word of it. Caitlin Clark announced she will not participate in the WNBA All-Star game. Colbert is not ending his run. CBS is throwing in the late night towel. Democrats want an investigation. Funky pancake frogs for sale. MSNBC's Chris Hayes is salivating. The UK really wants to be destroyed from within. Indy FOP Calls Out City Council for their Lack of Action in Addressing Soft on Crime Prosecutor and Revolving Door. All of the sudden the left cares about the rural areas, Netflix is a juggernaut, FDA getting rid of outdated rules. What will Trump with Too Late Jerome Powell? CNN Panelist questions if Trump was actually shot. Is Jimmy Kimmel next? See omnystudio.com/listener for privacy information.

In this episode of the Diabetes Innovators Series, the conversation explores the evolution of diabetes treatment, the challenges faced in managing diabetes today, and the future of diabetes research. Zan, an endocrinologist and former FDA executive and Founder and executive chairman of Kinexum, shares insights from his career, including the historical context of diabetes management, the importance of A1C as a marker, and the potential of new treatments like GLP-1 agonists. The discussion also touches on the concept of meta-abesity, the shared root causes of chronic diseases, and the need for a focus on health span rather than just lifespan. Chapters 00:00 Introduction to Diabetes Innovation Series 03:06 Zan's Journey in Diabetes Research 06:05 Transforming Diabetes Treatment: A Historical Perspective 09:00 The Evolution of Diabetes Management Tools 11:42 Challenges in Diabetes Management Today 14:41 The Future of Diabetes Treatment: Aiming for a Cure 17:57 Understanding the Drug Approval Process 20:32 Meta-Abesity: A New Perspective on Chronic Diseases 23:48 Innovations in Longevity and Health Span 26:27 The Role of GLP-1 Agonists in Diabetes Management 29:29 Future Directions in Diabetes Research 32:29 Memorable Moments in Drug Proposals 35:37 Conclusion and Future Collaborations Resources: Kinexum Zan Fleming

This week on The Progress Report, Zachary and Emma bring your antidote to the daily doom and gloom, from surprising political wins and innovative scientific breakthroughs to heartwarming stories that often go overlooked. The FDA's latest help for dog lovers, Australia's bold climate visa for Tuvaluans, and an unexpected bipartisan win for families are all covered here. What Could Go Right? is produced by The Progress Network and The Podglomerate.For transcripts, to join the newsletter, and for more information, visit: theprogressnetwork.orgWatch the podcast on YouTube: ⁠⁠⁠https://www.youtube.com/theprogressnetwork⁠⁠⁠And follow us on X, Instagram, Facebook, TikTok: @progressntwrk Learn more about your ad choices. Visit megaphone.fm/adchoices

Firefighters Use Narcan To Revive Puppy Exposed To FentanylThe Bottom Line:Firefighters in Lacey, Washington, saved an unresponsive puppy exposed to fentanyl by administering Narcan, a medication used to reverse opioid overdoses.The treatment was successful, and the puppy has recovered well.The fire department says such cases are rare, but they say they're always ready to handle all types of emergencies.The Full Story:Earlier this week, firefighters from Lacey Fire District 3 in Washington State found an unresponsive puppy inside a vehicle where fentanyl was present. The crew immediately administered a small dose of Narcan to the puppy, a medication commonly used to reverse opioid overdoses. The fire department says the treatment worked and the puppy is now doing well.Narcan, also known as naloxone, is an opioid antagonist that quickly reverses the effects of drugs like fentanyl by blocking opioid receptors. Fentanyl is a highly potent synthetic opioid, and according to the FDA, even a tiny amount can be dangerous for dogs. Despite the unusual nature of the situation, the firefighters' training enabled them to respond effectively and save the puppy.The Lacey Fire District 3 shared photos of the puppy wrapped in a blanket and receiving care, writing that while using Narcan on a dog is rare, their teams are prepared for all emergencies. The department expressed relief and pride in the successful rescue.Source: PEOPLE

This week, something extraordinary happened: menopause took center stage at the highest levels of US government in an unprecedented way. The US Food and Drug Administration (FDA) convened leading experts from across the country to discuss what millions of women have been waiting to hear: their experiences matter, their suffering is real, and there may be evidence-based solutions that have been withheld. This historic hearing offers tremendous hope for women navigating menopause.Are you ready to awaken your sensuality and feel more empowered in your body? Access the FREE Pleasure Upgrade Bundle at https://www.pleasureinthepause.com/gift.I am your host, Gabriella Espinosa, and in this special episode, I dive into the profound implications of this gathering. The FDA panel, the first of its kind in over two decades, aimed to fundamentally reimagine how we approach women's health during menopause, going beyond mere symptom management. This signifies a cultural awakening, recognizing that dismissing this universal experience has real consequences for women's health, careers, relationships, and quality of life.In this episode, we discuss:The End of Silence: Menopause, once a shamed and dismissed topic, has finally entered serious public discourse, moving beyond quiet endurance to high-level recognition.A Personal Story Driving Change: The head of the FDA shared his personal story about his mother who suffered greatly due to outdated fears around hormone therapy, emphasizing that bone fractures in older women can be fatal.Dismantling Dogma: Experts revealed that vaginal estrogen is categorically safe for all women, with no systemic absorption, directly challenging the black box warning.The Cost of Fear: Data revealed that tens of thousands of women died over the past two decades simply by avoiding estrogen, highlighting the tragic triumph of fear over facts.Brain and Bone Health: Researchers presented alarming data on how estrogen decline impacts brain function and bone density, emphasizing that hormone therapy can be a critical prevention tool, not just a treatment for the elderly.This hearing signals a critical shift: women's health matters, our experiences are valid, and we deserve care based on current science, not outdated assumptions. Whether or not you choose hormone therapy, there is now hope that you can make informed decisions based on facts.Your voice matters in this conversation!The FDA is opening a public comment period on this topic. Please go to the FDA YouTube channel, listen to the full hearing, and leave your public comment. This is our opportunity to ensure today's expert testimony translates into policy changes that will help millions of women.Help us spread more pleasure in the world!Please subscribe, rate, and review this episode, and share it with someone you love. Your voice is crucial in creating ripples of pleasure and connection throughout our communities.Until we meet again, remember, your pleasure matters.FDA HearingFDA InstagramCONNECT WITH GABRReclaim your sensuality and step into a powerful new chapter. The Midlife Pleasure Collective is a monthly membership designed to help midlife women reconnect with their bodies, embrace their desires, and cultivate deeper pleasure. Join the founding members for just $20/month - spots are limited, so apply now at pleasure-in-the-pause.com/collective. Full episodes on YouTube.

New indication for Kerendia; investigational therapy shows promise for hypertension; Novolog interchangeable biosimilar gets approval; trial results for hormone-free contraceptive; Shingrix now supplied in a prefilled syringe.

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in the Pharma and Biotech world. Sarepta Therapeutics has recently experienced an 18% increase in its stock value following a significant business overhaul, which included staff layoffs and pipeline shifts. Analysts are cautiously optimistic about the company's future. At the same time, patients are advocating for access to Brainstorm Cell Therapeutics' ALS drug, Nurown, after promising results from an expanded access program. In other news, Novartis is in the process of reshoring its drug manufacturing operations in the US, a move that may take several years to complete. Additionally, a notable number of employees have departed from the FDA's Center for Drug Evaluation and Research amidst an overhaul by the Department of Health and Human Services. These developments underscore the continuous changes and challenges within the pharmaceutical industry. Sarepta Therapeutics recently announced a strategic overhaul, which involved cutting 500 staff members and shifting focus to sirna platform assets. This decision came after two patients passed away following treatment with its Duchenne muscular dystrophy gene therapy, Elevidys. The company has also added a black box warning for acute liver injury and failure to Elevidys as it pivots away from gene therapy programs.

Sean bienvenidos a un nuevo Spaces en directo desde Twitter. Esta será una entradilla corta para hablar sobre los orígenes del poder de la familia Kennedy, para ello voy a utilizar un artículo de la web vigilant citizen,ciudadano vigilante, una especie de técnico preocupado pero de USA. Dice así: “Los Kennedy fueron considerados, en su momento, la Familia Real de Estados Unidos: una poderosa dinastía que además era querida y admirada por el público. Sin embargo, la asombrosa "Maldición Kennedy" impactó profundamente a la familia, ya que numerosos miembros perdieron la vida a temprana edad y en extrañas circunstancias. Esta serie de artículos revelará datos menos conocidos sobre los Kennedy y explicará cómo el destino de la familia se relaciona con el gobierno en la sombra que gobierna Estados Unidos. Joseph Patrick Kennedy Sr. fue quien orquestó el ascenso de la familia al poder. Fue una figura destacada del Partido Demócrata y de la comunidad católica irlandesa de Estados Unidos. También fue un exitoso hombre de negocios, pues amasó una fortuna comprando y fusionando varios estudios cinematográficos de Hollywood e importando y distribuyendo bebidas alcohólicas en Estados Unidos después de la Ley Seca. Durante su carrera política, Kennedy se convirtió en un asesor cercano del presidente Franklin D. Roosevelt y fue nombrado presidente inaugural de la Comisión de Bolsa y Valores de Estados Unidos (SEC). En 1938, fue nombrado embajador de Estados Unidos en el Reino Unido, un prestigioso cargo donde estableció vínculos con la nobleza británica y presenció los inicios de la Segunda Guerra Mundial. Trató con personas pertenecientes a los "linajes Illuminati" (según la definición de Fritz Springmeier), como los Rothschild, los Astor y los Sassoon. Mantuvo una estrecha relación con el magnate periodístico y figura destacada de los Illuminati, William Randolph Hearst, quien posteriormente contribuyó al despegue de la carrera de JFK. Durante la carrera política de Kennedy Sr., asesoró a Roosevelt, masón de grado 33 y primer Gran Maestro Honorario de la Orden de DeMolay. Roosevelt, quien también fue asesorado por los notables ocultistas Manly P. Hall y Nicholas Roerich, ordenó la colocación del Sello de los Estados Unidos (el símbolo Illuminati de la pirámide con el ojo que todo lo ve) en el billete de dólar. Joe Kennedy Sr. también formó parte de varias órdenes de élite, como los Caballeros de Malta y la Sociedad de Peregrinos, un grupo altamente secreto que incluía entre sus miembros a los Rockefeller, los Vanderbilt, JP Morgan, miembros de la realeza británica, varios líderes de la Sociedad Skull and Bones, masones, Caballeros Templarios y presidentes de la Reserva Federal, así como ejecutivos de importantes empresas y medios de comunicación. De hecho, la Sociedad de Peregrinos es probablemente el grupo de élite más influyente que existe. En 1944, Kathleen, hija de Joe Kennedy, se casó con William Cavendish, duque de Devonshire (un cargo muy prestigioso dentro de la nobleza británica). El duque de Devonshire era Gran Maestro de la Gran Logia Unida de Inglaterra, el órgano rector de la mayoría de los masones en Inglaterra, Gales, Estados Unidos y la Commonwealth. Tras el fallecimiento prematuro de su hija, Joseph Kennedy declaró: Si Kathleen y su esposo vivieran, yo sería el padre de la duquesa de Devonshire (primera dama de compañía de la reina) y el suegro del líder de todos los masones del mundo. Por lo tanto, Joseph Kennedy estaba muy bien conectado con la élite oculta y los linajes Illuminati de Estados Unidos y Gran Bretaña. Si bien albergaba la esperanza de convertirse en candidato presidencial, su oportunidad se cerró cuando, ante la amenaza de una invasión nazi, declaró que «la democracia en Gran Bretaña ha terminado», añadiendo que «la batalla por Gran Bretaña no se trata de democracia, eso son puras tonterías». A puerta cerrada, Kennedy también fue descubierto simpatizando con Hitler y el movimiento nazi. También se le citó profiriendo diversas declaraciones antisemitas en conversaciones con los Astor. Consciente de que la indignación que causaba le impediría llegar a la presidencia, Kennedy padre actuó entre bastidores y se concentró en «colocar» a sus hijos en puestos de poder. Tenía la riqueza y, aún más importante, los contactos con la élite necesarios para que sus planes se hicieran realidad.” Robert F. Kennedy Jr., nacido el 17 de enero de 1954 en Washington D.C., es un abogado, activista ambiental y figura pública estadounidense, y su reciente papel como Secretario de Salud y Servicios Humanos (HHS) desde febrero de 2025, lo que ha generado controversia, especialmente por sus políticas sobre vacunas. Conocido por ser parte de la influyente familia Kennedy. Hijo de Robert F. Kennedy, exfiscal general y senador, y sobrino del presidente John F. Kennedy, ha forjado su propio camino, centrándose principalmente en el activismo ambiental y, más recientemente, en posturas controvertidas sobre la salud pública. Como presidente de la Waterkeeper Alliance (Alianza para la protección del agua), una organización dedicada a la protección de los recursos hídricos, Kennedy ha liderado esfuerzos para combatir la contaminación y promover esa palabreja tan manida por los de la agenda 2030, la sostenibilidad, ganándose reconocimiento por su trabajo en defensa del medio ambiente. Su trayectoria como abogado ambientalista incluye casos destacados contra grandes corporaciones por daños ecológicos, aunque si rascamos un poco vemos que la asociación Riverkeeper, la organización fundadora del movimiento fue la que logro la recuperación del rio Hudson por mas de mil millones de dólares. Ambas organizaciones fueron pioneras en reclamar la "restauración" de los ríos, un eufemismo que en realidad significa la destrucción de presas y otras infraestructuras hidráulicas y energéticas. Modelo que se ha replicado en todo el mundo golpeando especialmente a España. Los otros litigios han sido muy mediáticos pero en realidad hablamos de poco dinero y poca afectación para las multinacionales que contaminan el planeta de verdad. Kennedy comenzó su carrera profesional como asistente de distrito en Manhattan y, en la década de 1980, se unió a organizaciones como Riverkeeper y el Consejo de Defensa de Recursos Naturales (NRDC), enfocándose en la protección ambiental. En 1986, se convirtió en profesor adjunto de derecho ambiental en la Universidad Pace y, en 1987, fundó la Clínica de Litigios Ambientales de Pace. En 1999, fundó Waterkeeper Alliance, de la cual fue presidente durante 21 años, liderando esfuerzos globales para proteger los recursos hídricos. Su trabajo incluyó demandas exitosas contra municipios y corporaciones por violaciones de la Ley del Agua Limpia, consolidándolo como una voz prominente en la defensa del medio ambiente. Recibió reconocimientos como "Héroe del Planeta" de la revista TIME y el Premio Sartisky a la Paz, reflejando su impacto en este ámbito. Nosotros sabemos que Roma no premia a traidores, ergo, el no ha traicionado a Roma. Su carrera inicial se centró en la conservación de ecosistemas y la lucha contra la contaminación, especialmente en el impacto de estas en la salud humana. En 2014, co-fundó Children's Health Defense, una organización dedicada a abordar el aumento de condiciones crónicas infantiles, como el autismo, lo que marcó su transición hacia temas de salud pública. Children’s Health Defense (CHD), fundada por Robert F. Kennedy Jr., mantiene una postura crítica hacia la vacuna triple vírica (MMR, contra sarampión, paperas y rubéola), centrada en cuestionar su seguridad, eficacia y obligatoriedad. Esta afirmación se basa en el estudio de Andrew Wakefield de 1998, que relacionaba la MMR con el autismo. Dicho estudio fue retractado por supuestos fraudes científicos aunque si investigamos veremos que se trata de una argucia legal. A través de su sitio web, redes sociales y documentales como Vaxxed (coproducido por CHD), la organización difunde mensajes que cuestionan la MMR, alegando que los riesgos no se divulgan adecuadamente. Esta organización y sus posturas han sido criticadas por promover teorías conspirativas, como la idea de que la enfermedad de Lyme es un arma biológica, una afirmación que revivió en una audiencia del Senado el 5 de febrero de 2025. En los últimos años, Kennedy se ha posicionado como un crítico vocal de las políticas de vacunación, cuestionando el consenso científico y promoviendo escepticismo hacia las vacunas. Esto ha generado una polarización significativa, con seguidores que ven en él un defensor de la libertad individual y críticos que lo acusan de difundir desinformación. Sus libros, como “Timerosal: Que hable la ciencia” (2014), reflejan su enfoque en los supuestos riesgos de los conservantes en vacunas. Kennedy es un charlatán que solo está redefiniendo el negocio de los laboratorios mientras engaña, esperanza e ilusiona a los ingenuos. En unas recientes declaraciones dijo sobre las vacunas covid que “no superan los beneficios supuestos”, además de mencionar la “falta de datos de alta calidad que demuestren la seguridad de las vacunas de ARNm durante el embarazo” y la incertidumbre en cuanto a los beneficios para las madres gestantes y sus bebés”. Pero como podemos ver en la web del CDC, Notas del calendario de vacunación infantil, se sigue vacunando a bebes a partir de los 6 meses contra una enfermedad imaginaria como es el covid, con vacunas que se ha visto que presentan muchas reacciones adversas. Independientemente de las palabras de Kennedy al final las mujeres embarazadas son "personas de riesgo" para el CDC y por tanto se las recomienda vacunarse del covid. La administración bajo el mandato de Kennedy ha dicho que «todas las nuevas vacunas se someterán a pruebas de seguridad en ensayos controlados con placebo antes de su autorización», sin embargo la FDA acaba de aprobar una nueva inyección de Moderna sin un solo ensayo controlado con placebo. Los estudios con placebo empezarían a finales de este año y concluirían en 2027, pero la vacuna mNexspike de baja dosis ya esta en el mercado para personas de 65 años o mas o entre los 12 y 64 con al menos uno o más factores de riesgo subyacentes. Es más, Kennedy está permitiendo que siga la investigación para encontrar vacunas a la carta. Al respecto dijo: ”Un impulso para sustituir las vacunas de talla única por vacunas genéticamente personalizadas que sean seguras y eficaces para todos”. Leemos en una nota de prensa del Departamento de Salud y Servicios Humanos (HHS) del pasado 1 de mayo lo siguiente: “Washington, D.C. - Departamento de Salud y Servicios Humanos (HHS) y los Institutos Nacionales de Salud (NIH) anunciaron hoy el desarrollo de la plataforma de vacunas universales de próxima generación, Generation Gold Standard, utilizando una plataforma de beta-propioctona (BPL) activada por todovirus. Esta iniciativa representa un cambio decisivo hacia la transparencia, la eficacia y la preparación integral, financiando el desarrollo interno de vacunas universales contra la gripe y el coronavirus de los NIH, incluidos los candidatos BPL-1357 y BPL-24910. Estas vacunas tienen como objetivo proporcionar una protección de amplio espectro contra múltiples cepas de virus propensos a pandemias como la gripe aviar H5N1 y los coronavirus como SARS-CoV-2, SARS-CoV-1, y MERS-CoV. Nuestro compromiso es claro: toda innovación en el desarrollo de vacunas debe basarse en la ciencia y la transparencia del patrón oro, y sometida a los más altos estándares de pruebas de seguridad y eficacia, dijo el secretario del HHS, Robert F. Kennedy, Jr.” Nos están hablando no solo del covid, si no de la gripe aviar y el virus MERS… En abril de 2024, Kennedy lanzó una campaña para la nominación presidencial del Partido Demócrata, pero en octubre de ese año anunció que correría como independiente, rompiendo con el partido al que su familia ha estado históricamente vinculada. Su campaña se centró en temas como la libertad individual, la transparencia gubernamental y la reforma del sistema de salud, pero enfrentó desafíos en términos de apoyo y cobertura mediática. El 23 de agosto de 2024, suspendió su campaña y respaldó a Donald Trump en un mitin en Arizona, con la intención de mantener su presencia en la boleta en estados no competitivos. Este movimiento fue visto como una estrategia para influir en la política nacional, especialmente en temas de salud. El 14 de noviembre de 2024, Donald Trump lo nominó para el cargo de Secretario de Salud y Servicios Humanos (HHS), un puesto que asumió el 13 de febrero de 2025, tras una confirmación ajustada en el Senado con un voto de 52 a 48, donde Mitch McConnell fue el único republicano en votar en contra. Este nombramiento marcó un hito, ya que Kennedy se convirtió en el primer candidato presidencial independiente en ocupar un puesto de gabinete después de postularse para la presidencia. Su confirmación enfrentó oposición, con más de 17,000 médicos firmando una carta en enero de 2025 instando al Senado a rechazar su nominación, reflejando las preocupaciones sobre sus posturas en salud pública. Robert F. Kennedy Jr., al asumir el cargo de secretario de Salud y Servicios Humanos (HHS), poseía una cartera de inversión considerable que incluía acciones en empresas que, en teoría, debería regular en su rol. Según una carta de información presentada el 21 de enero de 2025, a pocos días de asumir su cargo, ante la Oficina de Ética Gubernamental de Estados Unidos, RFK Jr. se comprometió a desinvertir en varias compañías, incluidas las biotecnológicas CRISPR Therapeutics y Dragonfly Therapeutics, en un plazo de 90 días si era confirmado para el puesto. El invertía en empresas de terapias genéticas tales como CRISPR Therapeutics y Dragonfly mientras advertía de los riesgos de esas mismas terapias a través de su Fundación Children's Health Defens, en lo que consideramos una acción hipócrita. Un documento separado detalla un extenso listado de relaciones económicas, que incluye inversiones en empresas destacadas como Amazon, Apple, Vanguard, Citibank, Deutsche Bank, Rockefeller Access Fund, Disney, Warner Bros, entre otras, evidenciando la magnitud de su portafolio. Desde su toma de posesión, Kennedy ha implementado una serie de políticas controvertidas. El 13 de febrero de 2025, firmó la Orden Ejecutiva 14211, creando la Comisión "Make America Healthy Again" (MAHA), que preside, con el objetivo de investigar las enfermedades crónicas infantiles y evaluar las amenazas de los medicamentos con receta. El 22 de mayo de 2025, lanzó el informe MAHA, que posteriormente fue criticado por contener citas a estudios inexistentes, con la Casa Blanca atribuyendo los errores a problemas de formato. El 29 de mayo de 2025, se informó que su equipo agregó nuevos errores al informe, empeorando la situación. Otras acciones incluyen el despido de aproximadamente 5,200 trabajadores federales de salud recién contratados de agencias como los CDC y el NIH el 14 de febrero de 2025, y la eliminación de la mayoría del personal del Instituto Nacional para la Seguridad y Salud Ocupacional en abril de 2025, cancelando programas como las aprobaciones de equipos de seguridad para el lugar de trabajo y la investigación sobre la salud de los bomberos. El 9 de junio de 2025, removió a los 17 miembros del Comité Asesor sobre Prácticas de Inmunización (ACIP) de los CDC y los reemplazó con nuevos miembros, una decisión que generó críticas por potenciales conflictos de interés. El 20 de febrero de 2025, instruyó a los CDC a suspender las campañas publicitarias de vacunación contra la gripe durante una temporada de influenza severa, enfocándose en el "consentimiento informado". Durante un brote de sarampión en el suroeste de los Estados Unidos en 2025, que reportó 146 casos, 20 hospitalizaciones y 1 muerte en Texas a finales de febrero, Kennedy hizo comentarios públicos el 26 de febrero de 2025, afirmando falsamente que hubo dos muertes y cuatro brotes ese año (16 en 2024), y sugirió que la cuarentena fue la principal razón de las hospitalizaciones, lo cual fue refutado. Promovió tratamientos marginales como el aceite de hígado de bacalao y la vitamina A, y escribió un artículo de opinión en Fox News el 2 de marzo de 2025, calificando a las vacunas de "elección personal" y recomendando vitaminas, lo que llevó a informes de toxicidad por vitamina A en niños infectados. El 28 de marzo de 2025, enfrentó más críticas por promover tratamientos no convencionales, como vitaminas, lo que generó alarma entre los profesionales de la salud. El 25 de marzo de 2025, su desinformación llevó a la renuncia del principal encargado de la comunicación de salud pública de los CDC, y el 3 de marzo de 2025, el principal portavoz de HHS también renunció, citando "desinformación y mentiras". El 28 de marzo de 2025, el principal oficial de vacunas de la FDA también renunció por razones similares. En julio de 2025, Kennedy enfrenta demandas legales significativas. El 7 de julio de 2025, la Academia Americana de Pediatría, la Asociación Americana de Salud Pública y otras organizaciones médicas demandaron a HHS y a Kennedy por cambios unilaterales en las recomendaciones de vacunas, específicamente por eliminar las recomendaciones de vacunas contra el COVID-19, argumentando que estas acciones son ilegales. Estas demandas reflejan la creciente oposición de la comunidad médica a sus políticas. Además, el 25 de junio de 2025, acusó a Gavi, una agencia global de vacunas, de ignorar la ciencia en la inmunización de niños, una afirmación que ha sido controvertida y criticada por expertos. Robert F. Kennedy Jr. elogió recientemente la Operación Warp Speed, (lanzada en mayo de 2020, bajo la administración de Donald Trump, con el objetivo de acelerar el desarrollo, la producción y la distribución de vacunas, tratamientos y diagnósticos para la COVID-19), calificándola de "logro extraordinario" y "demostración de liderazgo" del expresidente Donald Trump. Esta declaración supone un cambio notable para Kennedy, que anteriormente había criticado la iniciativa. Sus comentarios se realizaron durante una audiencia en el Senado, destacando las complejidades de la lealtad política y la evolución de las narrativas que rodean el despliegue de la vacuna COVID-19 de la administración Trump. Las acciones de Kennedy como Secretario de HHS han generado un debate intenso sobre el equilibrio entre la libertad individual y la responsabilidad pública en salud. Su promoción de la iniciativa MAHA, incluyendo giras por estados como Oklahoma y Louisiana en julio de 2025, busca revolucionar el sistema de salud, pero muchos lo ven como una fuente de temor por su enfoque en teorías marginales y su rechazo al consenso científico. Su legado como activista ambiental sigue siendo notable, como dijimos fue miembro y directivo del grupo ambientalista Riverkeeper. El bagaje de esta ONG inspiró un libro cuyo prologo fue escrito por el también promotor de los créditos de carbono Al Gore. Robert Kennedy es un calentólogo que dio un discurso durante el concierto de la misma temática catastrofista llamado Live Earth que organizó David Rothschild y Al Gore entre otros. Robert F. Kennedy Jr durante “la Marcha Popular por el Clima” en Nueva York que se llevó a cabo el domingo 21 de septiembre de 2014 dijo: “que es lamentable que no existan leyes para reducir el escepticismo sobre el cambio climático entre los legisladores” y “"Ojalá existiera una ley que los castigara”. ¿No tiene ojos en la cara el señor Kennedy para ver que la geoingeneria está detrás del supuesto cambio climático? El ayuntamiento de Adeje, en la isla de Tenerife, le pago una visita para hablar sobre el cambio climático. Un ayuntamiento de un pueblo de 50.000 habitantes trae a una superestrella como el señor Kennedy para que les cuente una milonga que solo han visto unas 100 personas en Youtube. Les pondremos la charla en la descripción del podcast. Y es que hay mucho dinero para este tipo de campañas que en realidad promueven la Agenda 2030 al igual que otras supuestas luchas como la libertad sexual. RFK Jr. ha sido un luchador por la comunidad LGBT y el "matrimonio igualitario". En 2011 se unió a su Campaña de Derechos Humanos en Nueva York junto a Mike Bloomberg, Fren Drescher, Kevin Bacon, Whoopi Goldberg y otros. Es una marioneta mas del poder al igual que lo fue su tio o cualquier otro miembro de la familia Kennedy. El New York Post lo relacionó presuntamente con Epstein y el Lolita express, en un largo y documentado artículo publicado en diciembre de 2023. No solo muestra una fotografía de RFK Jr. y su amante durante una fiesta que ofreció Epstein en 1994 si no que recoge declaraciones del propio Kennedy reconociendo que viajo por lo menos dos veces en el avión del pederasta en compañía de niños. Su amante por aquel entonces que luego terminaría siendo su esposa, Mary Richardson Kennedy, se suicidó en 2012 dos años después de divorciarse de Kennedy. Por aquel entonces estaban empezando a salir a la luz los escándalos de Epstein. En el New York Post podemos leer: “Kennedy era tan cercano a Epstein que el multimillonario tenía una larga entrada para “Kennedy, Bobby y Mary” en su “pequeña libreta negra”, que incluía contactos de personas de la alta sociedad y políticos, así como de las jóvenes a las que agredió sexualmente.” Christina Oxenberg miembro de la depuesta familia real serbia (el príncipe Andrés de Gran Bretaña es primo segundo), es una vieja amiga de la familia Kennedy y escribió un libro en 2021 donde habla de esa relación: “Esos viajes tuvieron lugar hace aproximadamente 30 años, mucho antes de que la conducta criminal del Sr. Epstein fuera de conocimiento público”. “En junio de 1989, el magnate de la prensa británica Robert Maxwell organizó una fiesta en el Lady Ghislaine, a orillas del Potomac, en Washington, D. C. Entre los invitados se encontraban el reverendo Jesse Jackson, exsecretario de Defensa, el director de la CIA y dos Kennedy.” Robert Maxwell era el padre de la compinche de Epstein, la supuesta madame, que atraía y manejaba a las chicas jóvenes con las que Epstein chantajeaba a la flor y nata mundial. Una Doctora que huyó a México estuvo denunciando a este particular Kennedy de que le estaba enviando acoso mafioso organizado e intentos de asesinato con tipos de la C I A. Esto durante la plandemia, antes de ingresar como miembro del "gobierno" actual de USA. Por supuesto este tipo de noticias son tildadas de bulo por las agencias verificadoras. Pero conozcamos un poco de dónde vienen estas agencias. Y es que la CIA, las agencia de verificación y los Kennedy son como uña y carne como se puede ver en documentos desclasificados de la propia CIA. Desde 1985 la CIA planeó como introducir sus ideas en el público. Para ello se infiltró junto al FBI en varias universidades como la Escuela de Gobierno Kennedy de Harvard. Desde allí se empezaron a crear las primeras agencias de fact checking como Crosscheck y otras bajo agencias como First Draft...agencia cuya supervisión recae en la propia CIA. Para Maldita.es la verdad brota de estas fuentes. Como os digo la propia CIA dio una conferencia en 1987 para dejar claro que las mentes más privilegiadas debían compartir pupitre con algunos de sus agentes. Esto es ya es duro de por si...pero aún no es nada para lo que esconden estas agencias de verificación. Una pequeña búsqueda os arrojará quién está detrás de la financiación de las principales. Incluyendo las españolas maldito bulo y otras. Las Fundaciones Avina y Ashoka son sus principales garantes. Nuestros amigos de Desmontando a Babylon nos lo contaron en varias ocasiones como en BdlV - dab radio temporada 7.0 Episodio 03 No somos m ashokas Clara Jiménez Cruz, la cofundadora y CEO de Maldito Bulo fue elegida Ashoka Fellow (una changemaker) en 2019. ¿Qué es eso de Ashoka y de que va ese tema de los changemakers, los hacedores del cambio o emprendedores sociales? Básicamente hablamos de unas cuantas familias poderosas, entre ellas la suiza Schmidheiny y la belga Emsens y De Cartier, todas ellas propietarias de las multinacionales que explotaron el amianto, creando y financiando estas agencias de verificación con la complicidad, como no, de los Estados Unidos. Así que ya veis, las multinacionales que contaminaron con amianto todo el mundo occidental y que han provocado cientos de miles de muertes por cáncer están detrás de las agencias que verifican si la información es real. De esto no oiréis hablar nunca al flamante RFK Jr. Estamos ante un político que habla sin dejar clara su postura en muchos puntos importantes, por ejemplo, durante su comparecencia en la audiencia del 29 de enero de 2025 para considerar su nominación como Secretario de Salud y Servicios Humanos le hicieron esta pregunta sobre la IA: “La inteligencia artificial está transformando la investigación, el desarrollo y la prestación de servicios sanitarios. Tiene el potencial de mejorar la atención al paciente, los resultados sanitarios y la eficiencia. La IA también podría ser utilizada por los pagadores para limitar el acceso de los pacientes y crear obstáculos adicionales. ¿Qué papel cree que desempeñará el HHS en la gobernanza de esta tecnología transformadora?" Y esta fue su respuesta: “La inteligencia artificial tiene el potencial de cambiar fundamentalmente la forma en que se prestan los servicios sanitarios y los servicios humanos. Teniendo esto en cuenta, es posible que sea necesario considerar nuevas políticas y enfoques en toda la industria y el gobierno. El HHS puede apoyar mejor a los pacientes ofreciendo un entorno regulatorio claro y estable, cuando sea apropiado, con respecto a la seguridad, la eficacia y la transparencia, al tiempo que crea un amplio espacio para que el sector privado innove y amplíe la competitividad de Estados Unidos.” Le preguntaron sobre la transparencia. “Sr. Kennedy, la primera administración Trump tomó medidas importantes para mejorar la transparencia en la atención médica. Los programas y requisitos de transparencia en la atención médica, si se amplían, podrían ofrecer una oportunidad única para ayudar de manera significativa a reducir los costos de la atención médica y mejorar la calidad de los resultados. Si se confirma su nombramiento, ¿seguirá apoyando estos esfuerzos mediante la implementación de programas piloto de transparencia adicionales y políticas del HHS para ampliar aún más el trabajo que el gobierno federal ya ha comenzado en materia de transparencia?” Respuesta: R: “Si se confirma mi nombramiento, me comprometo a instaurar la transparencia en todos los programas y actividades del HHS, para que los estadounidenses puedan recuperar la confianza en el sistema sanitario. Además, espero con interés trabajar con el Congreso para presentar reformas legislativas que proporcionen a los estadounidenses una transparencia sin precedentes en su sistema sanitario.” Le preguntaron por la pandemia de Covid y se limito a contestar como lo haría un político. “La pandemia de COVID-19 puso de relieve el papel fundamental de la telesalud, que permite a los pacientes mantenerse en contacto con sus equipos de atención médica mientras permanecen seguros en sus hogares. Pero más allá de la pandemia, la telesalud sigue ofreciendo esperanza e innovación, desde el apoyo a los servicios de salud mental hasta la gestión de enfermedades crónicas, la mejora de la atención materna e incluso la solución de la escasez de personal en el sector sanitario. Presenté la Ley de Modernización de la Telesalud, un proyecto de ley bipartidista para hacer permanentes las flexibilidades de telesalud promulgadas durante la pandemia de COVID-19, con el fin de garantizar la cobertura continua y el acceso a la atención médica para los estadounidenses. Si se confirma, ¿cómo planea el HHS trabajar con el Congreso para garantizar que millones de beneficiarios de Medicare no pierdan el acceso a los servicios de telesalud y caigan abruptamente en el «precipicio de la telesalud»?” Respuesta: “La telesalud es una herramienta importante para proporcionar acceso a una gama de servicios de atención médica cruciales, especialmente para quienes viven en zonas rurales y en áreas con escasez de proveedores. Si se confirma mi nombramiento, espero trabajar con el Congreso para garantizar que los modos innovadores de prestación de atención médica, como la telesalud, maximicen la calidad y el acceso a la atención para los beneficiarios de Medicare.” Y es que durante el Covid se gano mucho dinero sometiendo a la población a medidas tan absurdas como usar un bozal que no servia para nada. Tenemos un escándalo en España que relaciona a la oficina de la Fundación Human Rights que dirige Kennedy con este tema de las mascarillas. El hijo de Nati Abascal se compró entre otras cosas un yate de 13 metros de eslora con sus comisiones. Encima bautizó a la embarcación como Feria en honor al titulo nobiliario que ostenta la familia, el del famoso pederasta Duque de Feria. Fue la presidenta de la universidad americana CIS, María Díaz de la Cebosa que es a la vez la persona que lleva en España la fundación Human Rights que preside Kennedy la que le facilitó al imputado Luis Medina el teléfono de Carlos Martínez-Almeida, el primo del alcalde de Madrid, José Luis Martínez-Almeida. Los dos empresarios imputados se llevaron 6 millones de euros de un contrato para la compra de material sanitario. El hijo de Naty Abascal y su exsocio, absueltos de estafar al Ayuntamiento de Madrid, todo quedo en agua de borrajas. Le preguntan sobre el SIDA y responde esto: “El presupuesto anual del Instituto Nacional de Alergias y Enfermedades Infecciosas impulsa investigaciones fundamentales; entre los ejemplos se incluyen el desarrollo exitoso de nuevas vacunas contra el VRS, un fármaco aprobado por la FDA que retrasa la aparición de la diabetes tipo 1, una vacuna de ARNm contra el VIH y mucho más. Explique por qué planea detener este trabajo y a quién beneficiará.” Respuesta: “Si se confirma mi nombramiento, espero evaluar todas las agencias y programas para asegurarme de que están cumpliendo la misión de devolver la salud a los estadounidenses.” Las agencias de verificación son un invento, como hemos visto antes, de las grandes multinacionales y estas mismas empresas siguen trabajando sin cortapisas bajo la administración de este supuesto antivacunas que no lo es tal. Estas agencias no nos contaran la verdad jamas y no hablaran de la relación de este Kennedy con los grupos antivacunas que promocionan en verdad la Agenda 2030 y la Nueva era. Ni de esto ni de la La trágica historia de Rosemary, la hermana de J.F. Kennedy a quien su padre mandó a lobotomizar. Yo no me fiaría mucho de una familia que es capaz de realizarle una lobotomía a una pobre joven con problemas derivados de su nacimiento. En el parto no pudo respirar por no dejar que saliera de forma natural esperando casi dos horas por un médico que no llegaba. Una criada mantuvo las piernas cerradas de la madre… Hablamos de una joven con pequeños trastornos de aprendizaje que llegó a socializar con la realeza británica. Fue expulsada de Inglaterra por las declaraciones de su padre que afirmaba “que Reino Unido no podía ganar la guerra y que la democracia había terminado”. Regreso a USA y al final fue recluida en un convento...era incontrolable y una Kennedy incontrolable es un problema de estado. En un articulo de BBC news leemos: “Encerrada en un convento, se volvió desafiante a las restricciones. Las monjas no pudieron controlarla. "Muchas noches", recordó la prima de Rosemary, Ann Gargan, "la escuela llamaba a decir que había desaparecido y la encontraban vagando por las calles a las 2 a.m.". Pronto se supo que Rosemary se estaba escapando, según un compañero paciente que compartió muchos años del confinamiento posterior de Rosemary, para ir a tabernas y encontrarse con hombres en busca de atención, consuelo y sexo, escribió Elizabeth Koehler-Pentacoff en The Missing Kennedy.” Su padre tenía aspiraciones políticas para sus hijos y Rosemary era un peligro así que decidió someterla a una lobotomía con solo 23 años. Seguimos leyendo en BBC news: “Tras perforar agujeros en el cráneo de Rosemary, Freeman insertó un cuchillo y comenzó a cortar los lóbulos frontales de su cerebro. Atada a la mesa, ella estaba despierta y aterrorizada durante el procedimiento. De repente, se quedó en silencio y cayó en la inconsciencia. La operación había sido un catastrófico fracaso. Rosemary quedó sin poder caminar ni hablar. Incluso después de años de terapia, no podía pronunciar más que unas pocas palabras y nunca recuperó completamente el uso de sus extremidades.” Murió en 2005, a los 86 años tras pasar 63 largos años aislada, recluida en centros de internamiento privados sin recibir visitas. Si son capaces de hacer eso con uno de los suyos, que no serán capaces de hacer con un extraño. A continuación se presenta una lista de los principales eventos considerados parte de la «Maldición Kennedy». Si bien es improbable que todos estos eventos fueran resultado de una conspiración contra la familia, es difícil ignorar el fuerte patrón de sincronicidad, también conocido como «coincidencias significativas», asociado con los Kennedy. 1941—Se creía a menudo que Rosemary Kennedy padecía problemas mentales. Algunas fuentes afirmaban que padecía enfermedades mentales, como depresión y esquizofrenia. Debido a sus cambios de humor cada vez más violentos y severos, su padre, Joe Sr., organizó en secreto que se sometiera a una lobotomía. La lobotomía, en cambio, deterioró aún más sus capacidades cognitivas y, como resultado, Rosemary permaneció internada hasta su fallecimiento en 2005. 12 de agosto de 1944—Joseph P. Kennedy, Jr. murió cuando su avión explotó sobre East Suffolk, Inglaterra, como parte del Proyecto Anvil. 13 de mayo de 1948—Kathleen Cavendish, marquesa de Hartington, murió en un accidente aéreo en Francia. 23 de agosto de 1956: Jacqueline Bouvier Kennedy dio a luz a una hija muerta, Arabella. (Aunque está enterrada en el Cementerio Nacional de Arlington junto a sus padres con una placa que dice "Hija", sus padres tenían la intención de llamarla Arabella). 9 de agosto de 1963—Patrick Bouvier Kennedy murió dos días después de su nacimiento prematuro. 22 de noviembre de 1963—El presidente estadounidense John F. Kennedy fue asesinado en Dallas, Texas. Lee Harvey Oswald fue acusado del crimen, pero Jack Ruby lo mató a tiros dos días después, antes de que pudiera celebrarse el juicio. El FBI y la Comisión Warren concluyeron oficialmente que Oswald fue el único asesino. Sin embargo, el Comité Selecto de la Cámara de Representantes de Estados Unidos sobre Asesinatos (HSCA) concluyó que dichas investigaciones presentaban graves deficiencias y que Kennedy probablemente fue asesinado como resultado de una conspiración. 19 de junio de 1964—El senador estadounidense Edward M. “Ted” Kennedy sufrió un accidente aéreo en el que fallecieron uno de sus asesores y el piloto. Fue rescatado de los restos por su colega senador Birch E. Bayh II y pasó semanas hospitalizado recuperándose de una fractura de espalda, un pulmón perforado, costillas rotas y una hemorragia interna. 5 de junio de 1968—El senador estadounidense Robert F. Kennedy fue asesinado por Sirhan Bishara Sirhan en Los Ángeles, inmediatamente después de su victoria en las primarias presidenciales demócratas de California. Sirhan fue declarado culpable del asesinato de Kennedy y cumple cadena perpetua en el Centro Correccional Richard J. Donovan. 18 de julio de 1969—En el incidente de Chappaquiddick, Ted Kennedy se cayó accidentalmente de un puente en la isla de Chappaquiddick, atrapando fatalmente a su pasajera, Mary Jo Kopechne, en su interior. En su declaración televisada del 25 de julio, Kennedy afirmó que la noche del incidente se preguntó si realmente pesaba una terrible maldición sobre todos los Kennedy. 13 de agosto de 1973—Joseph P. Kennedy II era el conductor de un automóvil que se estrelló y dejó a su pasajera, Pam Kelley, paralizada. 25 de abril de 1984—David Anthony Kennedy murió de una sobredosis de cocaína y Demerol en una habitación de hotel de Palm Beach, Florida. 31 de diciembre de 1997—Michael LeMoyne Kennedy falleció en un accidente de esquí en Aspen, Colorado . Kennedy era sospechoso de estupro tras mantener una relación de tres años con una niñera de 14 años. 16 de julio de 1999—John F. Kennedy, Jr. falleció cuando la avioneta Piper Saratoga que pilotaba se estrelló en el océano Atlántico frente a la costa de Martha's Vineyard debido a un error del piloto. Su esposa y su cuñada también fallecieron. – Wikipedia, “La maldición de Kennedy” ………………………………………………………………………………………. Conductor del programa UTP Ramón Valero @tecn_preocupado Canal en Telegram @UnTecnicoPreocupado Un técnico Preocupado un FP2 IVOOX UTP http://cutt.ly/dzhhGrf BLOG http://cutt.ly/dzhh2LX Ayúdame desde mi Crowfunding aquí https://cutt.ly/W0DsPVq Invitados Dra Yane #JusticiaParaUTP @ayec98_2 Médico y Buscadora de la verdad. Con Dios siempre! No permito q me dividan c/izq -derecha, raza, religión ni nada de la Creación. https://youtu.be/TXEEZUYd4c0 ………………………………………………………………………………………. Enlaces citados en el podcast: AYUDA A TRAVÉS DE LA COMPRA DE MIS LIBROS https://tecnicopreocupado.com/2024/11/16/ayuda-a-traves-de-la-compra-de-mis-libros/ La vida oculta de los Kennedy: La dinastía de la élite que fue diezmada (Parte I) https://vigilantcitizen.com/vigilantreport/kennedys-elite-dynasty-got-decimated-pt/ La vida oculta de los Kennedy: La dinastía de la élite que fue diezmada (Parte II) https://vigilantcitizen.com/vigilantreport/hidden-life-kennedys-elite-dynasty-got-decimated-pt-ii/ La vida oculta de los Kennedy: La dinastía de élite diezmada (Parte III) https://vigilantcitizen.com/vigilantreport/hidden-life-kennedys-elite-dynasty-got-decimated-pt-iii/ Moderna consigue aprobación de la FDA para mNexspike, su vacuna COVID de baja dosis con acceso limitado https://www.infobae.com/estados-unidos/2025/06/01/moderna-consigue-aprobacion-de-la-fda-para-mnexspike-su-vacuna-covid-de-baja-dosis-con-acceso-limitado/ Kennedy es un charlatán que solo está redefiniendo el negocio de los laboratorios mientras engaña, esperanza e ilusiona a los ingenuos. Se sigue vacunando a bebes a partir de los 6 meses. https://www.cdc.gov/vaccines/hcp/imz-schedules/child-adolescent-notes.html#note-covid-19 Independientemente de las palabras de Kennedy al final las mujeres embarazadas son "personas de riesgo" para el CDC y por tanto se las recomienda vacunarse del covid. https://www.nejm.org/doi/full/10.1056/NEJMsb2506929 FDA aprueba nueva inyección de Moderna sin un solo ensayo controlado con placebo https://cienciaysaludnatural.com/fda-aprueba-nueva-inyeccion-de-moderna-sin-ensayo-controlado/ PowerPoint de Children's Health Defense "El público exige una vacuna Covid-19 segura". "Lo que muchos quieren realmente es un programa de vacunas seguras para todos, 𝗳𝗼𝗿 𝘆𝗼𝘂 𝗮𝗻𝗱 𝗺𝗲, 𝗳𝗼𝗿 𝗰𝗵𝗶𝗹𝗱𝗿𝗲𝗻, 𝗳𝗼𝗿 𝘆𝗼𝘂𝗿 𝗴𝗿𝗮𝗻𝗱𝗰𝗵𝗶𝗹𝗱𝗿𝗲𝗻." "Un impulso para sustituir las vacunas de talla única por 𝗴𝗲𝗻𝗲𝘁𝗶𝗰𝗮𝗹𝗹𝘆 "𝗽𝗲𝗿𝘀𝗼𝗻𝗮𝗹𝗶𝘇𝗲𝗱" 𝗶𝗺𝗺𝘂𝗻𝗶𝘇𝗮𝘁𝗶𝗼𝗻𝘀 que sean seguras y eficaces para todos" Fuente de las diapositivas (13 y 54): https://childrenshealthdefense.org/protecting-our-future/covid-vaccine-safety-concerns/ Nota de prensa del Departamento de Salud y Servicios Humanos (HHS) del pasado 1 de mayo. Washington, D.C. - Departamento de Salud y Servicios Humanos (HHS) y los Institutos Nacionales de Salud (NIH) anunciaron hoy el desarrollo de la plataforma de vacunas universales de próxima generación, Generation Gold Standard, utilizando una plataforma de beta-propioctona (BPL) activada por todovirus. Esta iniciativa representa un cambio decisivo hacia la transparencia, la eficacia y la preparación integral, financiando el desarrollo interno de vacunas universales contra la gripe y el coronavirus de los NIH, incluidos los candidatos BPL-1357 y BPL-24910. Estas vacunas tienen como objetivo proporcionar una protección de amplio espectro contra múltiples cepas de virus propensos a pandemias como la gripe aviar H5N1 y los coronavirus como SARS-CoV-2, SARS-CoV-1, y MERS-CoV. Nuestro compromiso es claro: toda innovación en el desarrollo de vacunas debe basarse en la ciencia y la transparencia del patrón oro, y sometida a los más altos estándares de pruebas de seguridad y eficacia, dijo el secretario del HHS, Robert F. Kennedy, Jr. https://www.hhs.gov/press-room/hhs-nih-announces-generation-gold-standard.html Noticia de 11 de abril de 2025. La FDA aprueba vacuna de ARN mensajero contra la "gripe aviar". La FDA concedió la designación de vía rápida a una vacuna candidata de ARNm autoamplificante (ARCT-2304) para inmunización activa con el fin de proteger contra el subtipo H5N1 de la gripe A, también conocida como gripe aviar. La designación responde a la necesidad no cubierta de prevención del subtipo H5N1, que sigue siendo un riesgo sanitario mundial, y en noviembre de 2024 se inició un ensayo de fase 1 (NCT06602531) de la vacuna. https://www.drugtopics.com/view/fda-grants-fast-track-designation-for-potential-bird-flu-vaccine Robert Kennedy Jr invirtió en varias empresas de terapias genéticas tales como CRISPR Therapeutics y Dragonfly por un lado, mientras advertía de los riesgos esas mismas terapias a través de su Fundación Children's Health Defens por el otro. Dejo de participar en dichas empresas por los conflictos políticos que suponía su cargo sanitario en la Administración Trump no por conflictos éticos por su discurso contradictorio en Children's Health Defense. https://www.fiercebiotech.com/biotech/rfk-jr-will-divest-interests-crispr-tx-dragonfly-if-hhs-role-confirmed-letter Robert Kennedy es un calentólogo que dio un discurso durante el concierto de la misma temática catastrofista llamado Live Earth que organizó David Rothschild y Al Gore entre otros. https://youtube.com/watch?v=KG5zckBejK0&t=26s Robert F. Kennedy Jr. elogió recientemente la Operación Warp Speed, calificándola de "logro extraordinario" y "demostración de liderazgo" del expresidente Donald Trump. Esta declaración supone un cambio notable para Kennedy, que anteriormente había criticado la iniciativa. Sus comentarios se realizaron durante una audiencia en el Senado, destacando las complejidades de la lealtad política y la evolución de las narrativas que rodean el despliegue de la vacuna COVID-19 de la administración Trump. https://m.youtube.com/watch?v=xxOhOAXfjZw Robert F. Kennedy Jr: Los negacionistas del cambio climático deben ser castigados por ley Septiembre de 2014 https://www.al.com/news/2014/09/robert_f_kennedy_jr_climate-ch.html Robert Kennedy Jr presidió Waterkeeper, grupo ambientalista que acabó fusionándose con RiverKepper de la que también fue abogado. Ambas organizaciones fueron pioneras en reclamar la "restauración" de los ríos, un eufemismo que en realidad significa la destrucción de presas y otras infraestructuras hidráulicas y energéticas. Modelo que se ha replicado en todo el mundo golpeando especialmente a España. https://es.waterkeeper.org/revistas/volumen-14-n%C3%BAmero-2/deja-que-nuestros-r%C3%ADos-corran-libres/ Robert Kennedy Jr fue miembro y directivo del grupo ambientalista Riverkeeper. El bagaje de esta ONG inspiró un libro cuyo prologo fue escrito por el también promotor de los créditos de carbono Al Gore. https://en.wikipedia.org/wiki/The_Riverkeepers Robert Kennedy es un activista climático. Conferencia en español y en Adeje, Tenerife https://www.youtube.com/watch?v=GzW2APdiMJs RFK Jr. ha sido un luchador por la comunidad LGBT y el "matrimonio igualitario". En 2011 se unió a su Campaña de Derechos Humanos en Nueva York junto a Mike Bloomberg, Fren Drescher, Kevin Bacon, Whoopi Goldberg y otros. https://youtu.be/66DspDO3Oyo Una Doctora que huyó a Mexico estuvo denunciando a este particular Kennedy de que este tipo le estaba enviando Acoso mafioso organizado e intentos de asesinato con tipos de la C I A. Esto en etapa de plandemia, antes de ingresar como miembro del "Robierno" actual de Usa. se lo relacionó presuntamente con Epstein y el Lolita express, presuntamente señor juez, como diría Ramón. https://nypost.com/2023/12/08/news/pictured-robert-f-kennedy-jr-and-jeffrey-epstein/ Robert F. Kennedy Jr. retirará sus inversiones en dos biotecnológicas si es confirmado para dirigir el Departamento de Salud y Servicios Humanos (HHS). Como secretario de Sanidad, RFK Jr. dijo que desinvertiría en varias empresas -incluidas CRISPR Therapeutics y Dragonfly Therapeutics- en un plazo de 90 días, según una carta de información presentada el 21 de enero ante la Oficina de Ética Gubernamental de Estados Unidos. Otras empresas de la lista son Amazon y Apple. La carta que se refiere es esta: https://extapps2.oge.gov/201/Presiden.nsf/PAS+Index/F3C8425ED335BB5685258C1A00565D57/$FILE/Kennedy%2C%20Jr.%2C%20Robert%20F.%20%20AMENDED%20finalEA.pdf Y este es el documento separado donde declara un listado de relaciones económicas. Llama la atención los nombres de Vanguard, City Bank, Deustsche Bank, Rockefeller Access Fund, Disney, Warner Bros, etc https://extapps2.oge.gov/201/Presiden.nsf/PAS+Index/A56222F259495B0D85258C1A00565073/$FILE/Kennedy%2C%20Jr.%2C%20Robert%20F.%20%20AMENDED%20final278.pdf La trágica historia de Rosemary, la hermana de J.F. Kennedy a quien su padre mandó a lobotomizar https://x.com/tecn_preocupado/status/1299723370892857344 La CIA en la escuela de gobierno Kennedy de Harvard https://x.com/tecn_preocupado/status/1781965457458712761 Audiencia para considerar la nominación de Robert F. Kennedy, Jr., de California, como Secretario de Salud y Servicios Humanos https://www.finance.senate.gov/hearings/hearingto-consider-the-nomination-of-robert-f-kennedy-jr-of-california-to-be-secretary-of-health-and-human-services María Díaz de la Cebosa, el supuesto 'enlace' entre Luis Medina y el primo de Almeida, admite que les puso en contacto https://cadenaser.com/2022/05/09/declara-maria-diaz-de-la-cebosa-el-supuesto-enlace-entre-luis-medina-y-el-primo-del-almeida-en-el-caso-mascarillas/ El yate que compró el hijo de Naty Abascal con la comisión de las mascarillas para Madrid https://www.elindependiente.com/espana/2022/04/06/el-yate-que-compro-el-hijo-de-naty-abascal-con-la-comision-de-las-mascarillas-para-madrid/ "Caso mascarillas": el hijo de Naty Abascal y su exsocio, absueltos de estafar al Ayuntamiento de Madrid https://www.larazon.es/madrid/caso-mascarillas-hijo-naty-abascal-exsocio-absueltos-estafar-ayuntamiento-madrid_2025031967da93fc6e9585000103b2e5.html Diagrama falsa disidencia anti vacunas https://t.me/MiVidaMiOxigeno/13790 ………………………………………………………………………………………. Música utilizada en este podcast: Tema inicial Heros Epílogo El Último de la Fila - Lejos de las leyes de los hombres (Versión 2023) https://www.youtube.com/watch?v=_tkV4PmfJx4

The Senate narrowly approved the Trump administration's request to claw back about $9 billion for humanitarian foreign aid projects and the Corporation for Public Broadcasting — but refused to cut funding for the international AIDS/HIV program PEPFAR. The House has a Friday deadline to approve the rescissions bill, or the funding remains in place. Meanwhile, a federal appeals court ruled that West Virginia can ban the abortion pill mifepristone, which could allow states to block other drugs approved by the FDA. Shefali Luthra of The 19th, Sandhya Raman of CQ Roll Call, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine join KFF Health News' Julie Rovner to discuss these stories and more. Plus, for “extra credit” the panelists suggest health policy stories they read this week that they think you should read, too: Julie Rovner: The New York Times' “UnitedHealth's Campaign to Quiet Critics,” by David Enrich. Joanne Kenen: The New Yorker's “Can A.I. Find Cures for Untreatable Diseases — Using Drugs We Already Have?” by Dhruv Khullar. Shefali Luthra: The New York Times' “Trump Official Accused PEPFAR of Funding Abortions in Russia. It Wasn't True,” by Apoorva Mandavilli. Sandhya Raman: The Nation's “‘We're Creating Miscarriages With Medicine': Abortion Lessons from Sweden,” by Cecilia Nowell. Hosted on Acast. See acast.com/privacy for more information.

Ep 219 | This episode of Discover Ag with Natalie and Tara is a wild ride through ranch life, viral food claims, relatable garden fails, and the chaos of food dye policy. First up: Ree Drummond is back

The 2012 FDA approval of PrEP as a tool for HIV prevention gave HIV-negative queers anxiety-free access to the sexual freedoms of the 1970s. But writer Daniel Sanchez Torres says PrEP didn’t exactly make things easier for HIV positive folks who still face stigma, rejection, and fetishization from HIV negative folks. In this episode Chris, Gabe and Daniel discuss the varied impacts of PrEP and U=U on their sex and cruising experiences. Then, a listener shares a cruising confession about an encounter that has our hosts very, very afraid… Follow Sniffies' Cruising Confessions: cruisingconfessions.com Try Sniffies: sniffies.com Follow Sniffies on Social: Instagram: instagram.com/sniffiesapp X: x.com/sniffiesapp TikTik: tiktok.com/@sniffiesapp Follow the hosts: Gabe Gonzalez: instagram.com/gaybonez Chris Patterson-Rosso: instagram.com/cprgivesyoulife Guests featured in this episode: Daniel Sanchez-Torres: https://www.instagram.com/sup_dst/ supdst.com supdst.com/newsletter Everything Matters Press https://www.instagram.com/everythingmatters.press/ https://everythingmatters.press/shop/See omnystudio.com/listener for privacy information.

Mark Fox isn't your average entrepreneur. Former NASA engineer, creative inventor, hot air balloonist, and now the unconventional mind behind Resona Health, he's challenging everything we thought we knew about how healing works.In this episode, we dive deep into resonance frequency therapy — a form of non-invasive bioenergetic medicine that uses targeted pulsed electromagnetic fields (PEMF) to support cellular regeneration, nervous system balance, and the body's natural ability to heal. Whether it's anxiety, arthritis, chronic pain, PTSD, insomnia, or digestive dysfunction, Mark believes frequency is the missing link in modern medicine — and he's backing it with bold ideas, wild stories, and clinical evidence that just might make you rethink everything.We cover:The return to cellular balanceWhat exactly PEMF therapy is and how it differs from other energy modalitiesWhy resonance frequency therapy is helping people (and pets!) reduce pain, inflammation, and emotional trauma — often without pharmaceuticalsThe vagus nerve, emotional memory, and the surprising role of electromagnetic stimulation in regulating the nervous systemWhy Mark refuses to sell his healing tech on a subscription model, and why that's ruffled industry feathersThe story of how a giraffe study helped validate animal applications of frequency medicineWhat it's like to innovate in a space the FDA doesn't know how to regulateHow Resona Health's device delivers over 100 resonant frequencies tuned to support sleep, mood, detox, joint pain, immunity, and moreYou'll also hear how a personal trauma and the search for non-pharmaceutical relief led Mark down the frequency rabbit hole — and why he's now on a mission to give people the power to heal at home, affordably, and without dependency.Whether you're skeptical of alternative therapies or already experimenting with sound baths and red light panels, this conversation will leave you with a whole new appreciation for the science of energy medicine, biohacking, electromagnetic fields, and the art of self-regulation through resonance.https://resona.healthConnect:Dr. Trip Goolsby & LeNae Goolsby are the co-founders of the Infinite Health Integrative Medicine Center, and are also the co-authors of the book “Think and Live Longer”.

Today on Raise the Line, we bring you the unlikely and inspiring story of a woman who was afraid of blood as a child but became an accomplished nurse; who struggled with learning disabilities but became an effective educator; and who, despite lacking business experience or knowledge of graphics, built a successful company that produces visually rich educational materials for nurses and other providers. “I think the theme of my life has been I have struggled with learning, and I didn't want other people to struggle,” says Jennifer Zahourek, RN, the founder and CEO of RekMed which has developed a sequential, interactive learning system that includes illustrated planners, books, and videos used by millions of students and providers. The initial focus was to provide nurses with everything they needed to know from “the basics to the bedside” but RekMed now offers content for medics, respiratory therapists, medical assistants, and veterinarians as well. Driven by her belief in the power of visual learning and her “just freakin' do it” attitude, Jennifer overcame her fear of launching a business and quickly realized just how well nursing had prepared her for the hard work and unpredictability of entrepreneurship. “Nursing teaches you how to just be resilient, to pivot, to delegate, to work on a team and to handle high stress. I think nurses could literally be some of the best entrepreneurs on the planet,” she tells host Lindsey Smith. Tune in to this lively and valuable conversation as Jennifer shares lessons from bootstrapping a publishing company, insights on the evolving landscape of healthcare education, and advice on embracing change in nursing, especially with the expanding role of AI. Mentioned in this episode:RekMed If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

To take advantage of the special offer in this episode, visit https://www.⁠JoBurgMeats.com/beginwithin and use code NATE15 for 15% off your order.The convenience food industry has us convinced that healthy equals complicated, expensive, and time-consuming. But what if I told you two guys just spent 18 months fighting federal regulators to prove that the healthiest snack doesn't need to be cooked to death or pumped full of preservatives?In this episode, I sit down with Jon Engelson and Joe Berg, the masterminds behind JoBurg Meats, who are revolutionizing the way we think about convenient nutrition. Their journey from regulatory nightmare to creating a two-ounce package that delivers the protein equivalent of a six-ounce steak will change how you think about fueling your fitness goals.Questions you'll find answers to:Why did it take 18 months to get FDA approval for the healthiest snack?What's the real difference between heat-treated and non-heat-treated protein products?How can one small dietary change create momentum for bigger health transformations?What makes this approach different from every other "healthy" snack on the market?Visit ⁠⁠⁠https://www.⁠JoBurgMeats.com/beginwithin  and use code NATE15 for 15% off your order.Chapters: 00:36 The Power of Small Changes01:21 Introducing JoBurg Meats03:35 Meet the Founders: Jon Engelson and Joe Berg06:46 The Journey to Health and Nutrition07:44 The Story Behind JoBurg Meats19:19 Challenges of Bringing a Product to Market25:43 The Importance of Maintaining Product Integrity28:38 Balancing Idealism and Commerce34:04 The Value of Investing in Health43:54 Encouraging Small Changes for Better Health46:30 Conclusion and Special OfferIf you're enjoying the Begin Within Health Show, please consider subscribing/following and leaving a 5-star review! It helps the show reach more people who could benefit from these conversations.Follow for more:⁠https://www.instagram.com/natesleger/⁠⁠https://www.tiktok.com/@natesleger⁠⁠https://www.facebook.com/groups/beginwithinfit⁠⁠https://www.youtube.com/@beginwithin3785⁠

Get ready for one of our most meaningful conversations yet. Dr. Chloe sits down with Elizabeth DeLuca—the powerhouse advocate whose late-night PubMed searches, cross-country lab visits, and “help-the-babies” fund-raising campaigns helped push Capsida's CAP-002 gene-therapy program all the way to FDA clearance. We unpack how this first-in-human trial aims to restore the missing STXBP1 protein, why the same technology could leapfrog into other rare epilepsies, and how a mother's promise to her daughter is changing the face of science.Quick linksCapsida CAP-002 press release – details on the FDA-cleared trial and how it works: https://capsida.com/capsida-receives-fda-ind-clearance-for-its-first-in-class-iv-administered-gene-therapy-for-stxbp1-developmental-and-epileptic-encephalopathy/ capsida.comSTXBP1 Foundation – join the registry, learn about natural-history studies, or donate: https://www.stxbp1disorders.org/ STXBP1 FoundationSupport our mission by shopping the herbal lines that fund this podcast and Remy's ongoing care: • Radical Roots Herbs – whole-plant, spagyric CBD formulas: https://RadicalRootsHerbs.com • Noxi Herbs – modular Chinese-herb system for women's hormones: https://NoxiHerbs.comHeads-up: We speak candidly about seizures, neuro-degeneration, and child loss. Estimated annual mortality for STXBP1 remains ~3 %—every child is one too many—and that stark reality fuels Elizabeth's drive and Dr. Chloe's daily fight for her son, Remy.Listen, share, and stand with the rare-disease community that defines our world.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Today we're talking FDA regulation rollbacks, cereal collabs, UV milk and American Girl DollsAs always, find us here!https://www.speakpipe.com/InTheWeedsWithBenRandallhttps://www.facebook.com/groups/774902433251568https://www.instagram.com/chefbenrandall/ https://podcasts.apple.com/us/podcast/in-the-weeds-with-ben-randall/id869521547intheweedswbr.comhttps://www.redbubble.com/people/enzwell/shopintheweedswbr@gmail.comhttps://www.ipetitions.com/petition/smoque

This podcast episode is designed to offer listeners a discussion about the FDA's evolving stance on animal testing and exploring thoughts on its potential phase-out for monoclonal antibody (mAb) therapies. Hosted by Zac Lloyd and featuring expert insights from Dr. Whitney Helms, Executive Director of Nonclinical Development, Large Molecule Discovery at Eli Lilly and Company, and Dr. Diann Blanset, consultant at Akkeri, Inc., this roundtable-style discussion unpacks the scientific, ethical, and regulatory implications of this paradigm shift. Whether you're deep in the biologics pipeline or navigating the changing CRO landscape, this episode offers valuable perspectives on what the future may hold—and how to prepare for it.

On this West Virginia Morning, Chris Schulz examines a decision from the Fourth Circuit Court of Appeals this week to allow limits on the sale of abortion medications – even those medications that the FDA has deemed to be safe and effective. Plus, harm reduction programs are controversial – and opponents often point to figures that suggest they aren't particularly effective. The post The Decision To Cut Abortion Meds And A Push To Strengthen Harm Reduction, This West Virginia Morning appeared first on West Virginia Public Broadcasting.

Many people struggling with chronic illness, fatigue, brain fog, or unexplained symptoms never find real answers because they're not addressing the root cause: cellular toxicity. In this episode, Dr. Robert Whitfield sits down with Dr. Daniel Pompa, a leading voice in cellular detox and functional medicine, to explore why so many people stay sick despite trying countless protocols. They break down how inflammation, toxic overload, and chemical exposure disrupt your body at the cellular level and what it actually takes to start healing. Whether you're dealing with hormonal imbalances, autoimmune symptoms, or post-explant recovery, this conversation is a must-listen for anyone interested in root-cause healing and natural detox strategies that work.

What happens when 3,500 staffers lose their jobs due to FDA layoffs, venture capital (VC) term sheets shrink, and AI drug-discovery startups raise $600 million rounds? Executive recruiter William Holodnak (ex-Fidelity, global biotech headhunter) breaks down 2025's wild hiring market—and how founders can still build A-teams.In this episode you'll learn:- Why the April-1 FDA layoffs could delay approvals—and open new career doors for ex-regulators. - The three traits VCs demand in first-time biotech CEOs during a funding slump. - How AI-driven platforms like Isomorphic Labs raised mega-rounds in a down market. - Immunology's surge and why oncology startups are pivoting. - Board-level recruiting tactics that de-risk your Series B.

Thank you for listening to The Peptide Podcast. If you enjoyed the show and want to support what we do, head over to our Partners Page. You'll find some amazing brands we trust—and by checking them out, you're helping us keep the podcast going. Today we're going to talk about how peptides might actually help heal your eyes. If that sounds wild, stick with me. There's some amazing early research showing how specific peptides may help with things like macular degeneration, diabetic eye disease, corneal wounds, and even age-related vision loss. We're going to break it all down in plain language, and I'll also explain how each peptide might actually work inside the eye. Let's jump in. AXT107  Let's start with AXT107 — a peptide designed to help stop the growth of abnormal blood vessels in the back of the eye. These rogue vessels are a major problem in conditions like wet macular degeneration and diabetic retinopathy. AXT107 is an injection that's given directly into the eye that targets VEGF and angiopoietin receptors, two major players in abnormal blood vessel growth. In animal studies, it not only stopped new vessels from forming, but also reversed existing damage. Bonus? It forms a little gel-like depot in the eye that slowly releases over time, so it may last longer than current injection-based treatments. BPC-157  If you've heard of peptides for gut repair or injury recovery, you've probably come across BPC-157. But it's also being studied for the eye, especially for corneal healing. BPC-157 eye drops seem to speed up corneal epithelial repair — that's the outer layer of your eye — while reducing inflammation. In rat studies, it helped close up corneal wounds faster, which means it might help with things like dry eye, abrasions, or even post-surgical healing. In fact, while most corneal abrasions fully heal within one to two weeks, BPC-157 can reduce the healing time by several days. Elamipretide (SS31) — The Mitochondria Booster This next peptide is especially intriguing — Elamipretide, also known as SS31. You might remember we've mentioned it before for its potential in age-related and neurodegenerative conditions like Alzheimer's and Parkinson's. But now, researchers are also exploring its role in slowing or even reversing age-related vision decline when given as an eye or subcutaneous injection. This peptide goes deep — literally — into the mitochondria of retinal cells, helping them work more efficiently. In aging mice, Elamipretide improved contrast sensitivity and even reversed some vision loss. So it's not just slowing decline — it may actually restore function. P21  The next peptide is P21. P21 is a neurotrophic peptide, which means it helps keep nerve cells healthy. In the eye, that's a huge deal for preserving vision. P21 protects photoreceptors and retinal pigment cells, while also calming inflammation when given as a subcutaneous injection. In aging rats with retinal damage, it helped reduce nerve cell death and slowed degeneration. Visoluten  Now let's talk about Visoluten, an oral peptide we've discussed before in a previous podcast. As a refresher, it's important to remember that Visoluten is a bioregulatory peptide that helps support the health of the retina—the part of your eye that converts light into the images you see. It works by supporting the metabolic activity of eye tissues, helping maintain healthy vision and improving the eye's ability to adapt to stress, aging, or challenging environmental conditions. Think of it like nutritional support for the eye — especially helpful for people dealing with screen fatigue, bright light exposure, or chronic eye stress.  This peptide helps support the eye's natural metabolic activity, which is key to keeping the retina functioning well and protecting it from things like oxidative stress and environmental wear and tear. Think of it as giving your eyes extra support to stay resilient, especially when they're under strain. Visoluten may also enhance blood flow to the eye, making sure the retina gets the oxygen and nutrients it needs to work properly. That's especially important for people with conditions like age-related macular degeneration or diabetic retinopathy, where poor circulation and tissue damage are part of the problem. Retinalamin  Another oral peptide, Retinalamin, is already being used in some clinical settings — especially in parts of Europe and Asia — for retinal diseases. It helps normalize vascular permeability in the retina and supports repair mechanisms. It's shown benefits in people with glaucoma and diabetic retinopathy, sometimes even improving visual acuity when given intramuscularly or as an injection around the eye. PEDF-Derived Peptides  Here's where things start to feel futuristic — researchers have developed peptides derived from PEDF, or pigment epithelium-derived factor. PEDF is a natural protein found in the eye — especially in the retina. It plays a protective role by preventing damage to light-sensitive cells, reducing inflammation, and blocking abnormal blood vessel growth. PEDF is considered one of the most powerful natural antioxidants and anti-angiogenic (anti–blood vessel growth) factors in the eye. They help protect photoreceptors from stress and damage — without needing gene therapy or injections. These peptides are being turned into eye drops that may slow or stop diseases like retinitis pigmentosa (a group of inherited eye diseases that cause the gradual breakdown of the retina, leading to vision loss that often starts with night blindness and progresses to tunnel vision). They also help with AMD, or age-related macular degeneration (an eye condition that affects the central part of the retina (the macula), leading to blurred or lost central vision, especially in older adults. PHSRN & FGLM-Amide  The next two peptides I want to talk about are PHSRN and FGLM-Amide. They are also being formulated as eye drops and are specifically focused on healing the cornea. They activate something called the fibronectin-integrin system, which basically helps the eye's outer surface cells stick together and heal faster. Great for persistent epithelial defects or those stubborn wounds that don't want to close. ALG-1001 (Luminate)  Finally, there's ALG-1001, also known as Luminate. A peptide that is administered directly into the eye. Luminate is a first-in-class peptide drug that targets integrin receptors in the retina—key players in abnormal blood vessel formation. Instead of targeting VEGF, like current treatments, Luminate blocks integrins upstream, preventing both the growth and leakage of harmful vessels — which can be helpful in AMD and diabetic eye disease. It also has a bonus effect: it helps gently separate the vitreous gel from the retina — a process called pharmacologic vitreolysis. This is especially helpful for people with vitreomacular traction (VMT), a condition where the gel pulls too hard on the retina, causing swelling or vision problems. In clinical studies, about 65% of patients had that pulling relieved after treatment — a result that normally requires surgery. What About Cosmetic Peptides for the Eye Area Just to clarify — eye creams with peptides like Matrixyl 3000, Copper Peptides, or Palmitoyl Tetrapeptide-7 are designed to help with puffiness, dark circles, and fine lines — but they don't affect the internal eye. They work by stimulating collagen in the skin around the eyes — and while great for cosmetic use, they won't help with things like glaucoma or macular degeneration. *Some Words of Caution Most of the peptides we talked about today are still in preclinical or early clinical stages. That means they're promising, but not FDA-approved just yet. So please — no DIY peptide eye drops or injections unless you're working directly with a qualified provider. And as always, if you're dealing with real eye problems, your first stop should be a board-certified ophthalmologist, not a Telegram group or a tweet thread. So there you have it — a quick tour through the exciting, ever-evolving world of peptide therapy for the eyes. From boosting mitochondria to healing corneal wounds, these tiny proteins might be shaping the future of vision care. If you found this episode helpful or interesting, go ahead and share it with someone who stares at screens all day — or your biohacker friend who's already two steps ahead. Thank you for listening to The Peptide Podcast. If you enjoyed the show and want to support what we do, head over to our Partners Page. You'll find some amazing brands we trust—and by checking them out, you're helping us keep the podcast going.  Until next time, be well, and as always, have a happy, healthy week.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Johnson & Johnson reported second-quarter earnings of $23.7 billion, driven by cancer and neuroscience drugs, exceeding analyst expectations. CEO Joaquin Duato set a target of $50 billion in oncology sales by 2030. Despite challenges in the industry, Johnson & Johnson remains optimistic about its oncology sales target as the biotech industry continues to navigate the evolving landscape of drug development and funding.In a difficult investing environment where IPOs are not guaranteed, AI-focused biotech unicorns are facing challenges in securing funding. GSK's Blenrep is facing setbacks as the FDA questions its efficacy in treating multiple myeloma, while AstraZeneca's amyloidosis asset failed to improve survival in a late-stage trial. The industry is also seeing the rise of women leaders like Audrey Greenberg and the team at Acadia, who are making significant contributions to the field.Biospace is launching a new weekly newsletter focused on critical manufacturing issues in the biopharma industry, covering developments and impacts on companies such as Roche, Sanofi, and Johnson & Johnson. The newsletter aims to provide deep dives, analysis, and roundups of the biggest manufacturing stories of the week every Tuesday. Stay informed with weekly analysis and updates on the changing landscape of manufacturing in the U.S.

On this episode of Vitality Radio, Jared launches a brand-new series celebrating time-tested natural remedies that are as relevant today as they were generations ago. “Grandma Was Right” kicks off with an exploration of one of the oldest and most iconic natural tonics: apple cider vinegar (ACV). Jared breaks down what makes ACV so powerful, from its centuries-old use for digestion and energy to its modern applications in blood sugar balance, kidney support, gallbladder health, and even muscle cramp relief. You'll learn about the science behind the “mother,” the difference between capsules, liquids, and gummies, and why vinegar might just be the most underestimated staple in your wellness cabinet. He also shares personal experiences and pro tips for using ACV effectively, especially if you're managing reflux, metabolic issues, or biliary sluggishness. If you've dismissed apple cider vinegar as just another health trend, this episode might change your mind—and your daily routine.Products:Vitality Nutrition Apple Cider Vinegar CapsulesZhou Apple Cider Vinegar Gummiesinner-eco Coconut Vinegar Gummies with ACVRoots & Leaves Fire CiderOld Amish Formulas for Reflux and Leg CrampsDynamic Health Apple Cider Vinegar - in store only Visit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.

In this sweeping exposé, the host weaves together a narrative of corruption, cover-ups, and collusion across America's most critical institutions. Revisiting the controversial claims of Sidney Powell, he traces how early warnings of Chinese counterfeit ballots and identity theft—once scorned as conspiracy theories—are now partly confirmed by recent FBI admissions of massive document smuggling tied to TikTok. He details how coordinated censorship by Big Tech preemptively stifled debate on election integrity, while federal agencies allegedly destroyed evidence. The conversation then pivots to the food and water Americans consume daily, condemning the FDA, EPA, and corporate giants for pumping artificial dyes and fluoride into products linked to cancer and neurological damage. From the manipulation of the census and gerrymandering to efforts by RFK Jr. and Ron DeSantis to purge toxins from the marketplace, the segments paint a picture of a country under siege—not only at the ballot box but also at the dinner table. This is a call to vigilance: the stakes are nothing less than public health, democratic legitimacy, and the future of the nation.

This podcast highlights three updates: Moderna's Spikevax COVID-19 vaccine is now fully FDA-approved for high-risk children 6 months to 11 years, though rare myocarditis remains a concern. A large study found first-trimester TMP-SMX antibiotics increase congenital malformation risks compared to β-lactams, reinforcing β-lactams as safer. Finally, a trial showed no cardiovascular benefit from taking blood pressure medication at bedtime versus morning dosing.

I love aging and also… I get botox. I love my laugh lines (obviously, we named our podcast after them) but I also want to age gracefully. I want to feel like the best version of myself as I get older and sometimes… that means I get a little help from someone with a laser and a medical degree. In this episode of Laugh Lines, we're pulling back the curtain on cosmetic procedures with my very own dermatologist (and not a paid spokesperson!), the amazing Dr. Sue Ellen Cox. Too many people whisper about this stuff when it should be okay to talk about it!In the show, we discuss botox, lasers, fillers, necks, jowls, and even something called “pre-juvenation.” Dr. Cox is a legend in the field—like "clinical trials for the FDA" kind of legend. This episode is for anyone who's botox-curious, laser-curious, or simply wondering what all this stuff actually does. No gatekeeping here—we're being honest about what we've tried and what questions to ask. Be sure to stay tuned for the Oxford comma justice and Gen Z slang confusion this week. Apparently “he cooked” doesn't mean he made dinner, according to our son. (PC even makes an appearance at the end of the show!) We love to hear from you, leave us a message at 323-364-3929 or write the show at podcast@theholdernessfamily.com. You can also watch our podcast on YouTube.Learn more about Dr. Sue Ellen Cox and Aesthetic Solutions: https://aesthetic-solutions.com/Visit Our ShopJoin Our NewsletterFind us on SubstackFollow us on InstagramFollow us on TikTok Follow us on FacebookLaugh Lines with Kim & Penn Holderness is an evolution of The Holderness Family Podcast, which began in 2018. Kim and Penn Holderness are award-winning online content creators known for their original music, song parodies, comedy sketches, and weekly podcasts. Their videos have resulted in over two billion views and over nine million followers since 2013. Penn and Kim are also authors of the New York Times Bestselling Book, ADHD Is Awesome: A Guide To (Mostly) Thriving With ADHD and winners on The Amazing Race (Season 33) on CBS. Laugh Lines is hosted and executive produced by Kim Holderness and Penn Holderness, with original music by Penn Holderness. Laugh Lines is also written and produced by Ann Marie Taepke, and edited and produced by Sam Allen. It is hosted by Acast. Thanks for listening! Hosted on Acast. See acast.com/privacy for more information.

BONUS EP FROM LAST MONTH, PLUS MEMBERS GET NEW ROUNDUPS EVERY MONDAY, SIGN UP AT GRIMERICAOUTLAWED.CA   Is the Black Eye club at play? What about the secret space program... hints of John Dee and Enochian Magic. Or the Judas Protocol?   Breaking news about CDC and RFK Jr, dismantling the vaccine committee, new two year study showing the failure of the FDA and the majority of drugs. Does Elon really have all the spaceships? Is MAGA to blame for LA Riots? Program insiders might be summoning again.. Greta's boat boarded by the IDF. Phones in the water. What did the founder of Telegram tell Tucker about the USA Gov?   Support and extra content http://www.grimericaoutlawed.ca/support. Substack and Subscribe. https://grimericaoutlawed.substack.com/ or to our Locals  https://grimericaoutlawed.locals.com/ or Rokfin www.Rokfin.com/Grimerica Patreon https://www.patreon.com/grimericaoutlawed   Support the show directly: https://grimericacbd.com/ CBD and THC Tinctures and Gummies! https://grimerica.ca/support-2/ http://Grimerica.ca/shrooms and Micro Dosing The Eh-List YouTube Channel: https://youtube.com/@theeh-list?si=d_ThkEYAK6UG_hGX Our Adultbrain Audiobook Podcast and Website: www.adultbrain.ca Our Audiobook Youtube Channel:  https://www.youtube.com/@adultbrainaudiobookpublishing/videos Darren's book www.acanadianshame.ca Check out our next trip/conference/meetup - Contact at the Cabin www.contactatthecabin.com www.grimerica.ca/Shrooms  and Micro-Dosing Other affiliated shows: www.grimerica.ca The OG Grimerica Show www.Rokfin.com/Grimerica Our channel on free speech Rokfin Join the chat / hangout with a bunch of fellow Grimericans Https://t.me.grimerica https://www.guilded.gg/chat/b7af7266-771d-427f-978c-872a7962a6c2?messageId=c1e1c7cd-c6e9-4eaf-abc9-e6ec0be89ff3 Leave a review on iTunes and/or Stitcher: https://itunes.apple.com/ca/podcast/grimerica-outlawed http://www.stitcher.com/podcast/grimerica-outlawed Sign up for our newsletter http://www.grimerica.ca/news SPAM Graham = and send him your synchronicities, feedback, strange experiences and psychedelic trip reports!! graham@grimerica.com InstaGRAM https://www.instagram.com/the_grimerica_show_podcast/ Purchase swag, with partial proceeds donated to the show www.grimerica.ca/swag Send us a postcard or letter http://www.grimerica.ca/contact/ ART - Napolean Duheme's site http://www.lostbreadcomic.com/ MUSIC Tru Northperception, Felix's Site sirfelix.bandcamp.com   Links to the stuff we chatted about: https://x.com/OMApproach/status/1932059888122753337 https://x.com/DataRepublican/status/1932105886241378456 https://x.com/covertress/status/1931768944786129187 https://x.com/UAPWatchers/status/1930964205802278914 https://x.com/AmurakaHidden/status/1930767977055506871 https://www.instagram.com/p/DKabdjzotdS/ https://palexander.substack.com/p/did-i-not-tell-you-this-in-a-prior?utm_source=post-email-title&publication_id=579356&post_id=165420260&utm_campaign=email-post-title&isFreemail=true&r=24pqe&triedRedirect=true&utm_medium=email https://naomiwolf.substack.com/p/brian-and-naomi-in-the-lair?utm_source=post-email-title&publication_id=676930&post_id=165564236&utm_campaign=email-post-title&isFreemail=true&r=24pqe&triedRedirect=true&utm_medium=email https://apnews.com/article/kennedy-cdc-acip-vaccines-3790c89f45b6314c5c7b686db0e3a8f9 https://x.com/free_bythesea/status/1931979525941789071?s=43 https://x.com/vigilantfox/status/1932178912265609498?s=43

In this week's Fraud Friday, Laci is joined by Sara Levine & Danny Murphy (Not Another True Crime Podcast) to discuss Elizabeth Swaney, who proudly made it to the 2018 PyeongChang Winter Games, without doing a single trick in her sport. Plus, the FDA demanded Alex Jones stop advertising questionable dietary supplements as coronavirus treatments, threatening legal action if he didn't stop. Stay Schemin'! (Originally Released 06/06/2022) CON-gregation, catch Laci's TV Show, Scam Goddess, now on Freeform and Hulu!Did you miss out on a custom signed Scam Goddess: Lessons from a Life of Cons, Grifts and Schemes book? Look no more, nab your copy here on PODSWAG Follow on Instagram:Scam Goddess Pod: @scamgoddesspodLaci Mosley: @divalaciSara Levine: @saralememeDanny Murphy: @kashmeredanny  Research by Kaelyn Brandt SOURCES:https://everything-everywhere.com/elizabeth-swaney-and-the-power-of-just-showing-up/https://olympics.com/en/news/elizabeth-swaney-unlikely-halfpipe-herohttps://resumes.actorsaccess.com/elizabethhttps://www.theguardian.com/us-news/2019/apr/21/elizabeth-swaney-olympics-skiing-american-ninja-warriorhttps://www.cbssports.com/olympics/news/mikaela-shiffrin-doesnt-have-anything-to-prove-to-anyone-at-the-beijing-olympics/ Subscribe to SiriusXM Podcasts+ to listen to new episodes of Scam Goddess ad-free and a whole week early. Start a free trial now on Apple Podcasts or by visiting siriusxm.com/podcastsplus.